Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

Citations Database Search Results

Download these results to MS Excel

720 records found for:
Title = Substance Use Disorders

  1. Gabrielian S, Chang ET, Treichler EBH, Barnard J, Nelson RE, Wong MS, Jackson NJ, Finley EP. Comparing two strategies to support the implementation of evidence-based practices for substance use disorders in VA's permanent supportive housing program: a protocol for a type 3 hybrid cluster-randomized controlled trial. Implementation science : IS. 2026 Mar 24 DOI: 10.1186/s13012-026-01498-z.
  2. Nguyen N, Leonard S, Byers AL, Austin PC, Krebs EE, Sandbrink F, Bravata DM, Keyhani S. Associations of Cannabis and Tobacco Use with Suicide Attempt, Suicide Death, and Overdose Death Among Veterans Prescribed Opioid Analgesics. American journal of preventive medicine. 2026 Feb 13; 108309, DOI: 10.1016/j.amepre.2026.108309.
  3. Shaffer PM, Andre M, Smelson D, Cucciare MA, Bruzios KE, Blonigen DM. Criminogenic risk and suicidality among justice-involved homeless veterans with comorbid mental health and substance use disorders. BMC public health. 2026 Feb 4; 26(1):DOI: 10.1186/s12889-026-26250-6.
  4. Abrams TE, Gravely A, Danan E, Shiroma P, Thuras P, Westanmo A. Mental Health Disorders Associated with Mammography Receipt Among Women Veterans. Journal of general internal medicine. 2025 Dec 10 DOI: 10.1007/s11606-025-10070-2.
  5. Pham NV, Singh R, Leng M, Han SB, May FP, Singh J, Benhammou JN. Mental health diseases are associated with active hepatitis C and partly drive HCC trends in Veterans. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2025 Nov 29 DOI: 10.1016/j.cgh.2025.11.026.
  6. Panelli DM, Esmaeili A, Joyce VR, Chan CS, Gujral K, Schmitt SK, Murphy NF, Kimerling R, Lockett M, Leonard SA, Main EK, Shaw JG, Phibbs CS. Association Between Mental Illness and Risk of Severe Maternal Morbidity in Pregnant Veterans. Obstetrics and gynecology. 2025 Oct 30 DOI: 10.1097/AOG.0000000000006107.
  7. Sheinfil AZ, Cucciare MA, Wolitzky-Taylor K, Cully JA, Lindsay JA, Ecker AH. Feasibility, Acceptability, and Preliminary Clinical Impact of a Computer-Assisted Transdiagnostic CBT Intervention for Veterans with Co-Occurring Anxiety and Substance Use Disorders. Journal of Dual Diagnosis. 2025 Oct 1; 1-11, DOI: 10.1080/15504263.2025.2559174.
  8. Kaufman V, Tomlinson DC, Hellman L, Lin LA, Fernandez AC, Coughlin LN. The path forward for substance use disorder treatment using contingency management under sect. 1115 demonstration waivers. Substance abuse treatment, prevention, and policy. 2025 Sep 30; 20(1):37, DOI: 10.1186/s13011-025-00666-6.
  9. Kinney AR, Brenner LA, Deka R, Yan XD, Forster JE, Ulmer CS, Pfeiffer PN, Ganoczy D, Martin JL, Yepson H, Bahraini NH. Guideline-Concordant Cognitive Behavioral Therapy for Insomnia in the Veterans Health Administration Polytrauma/Traumatic Brain Injury System of Care. Behavioral sleep medicine. 2025 Sep 26; 1-14, DOI: 10.1080/15402002.2025.2563555.
  10. Nateghi Haredasht F, Lopez I, Tate S, Ashtari P, Chan MM, Kulkarni D, Chen CA, Vangala M, Griffith K, Bunning B, Miner AS, Hernandez-Boussard T, Humphreys K, Lembke A, Vance LA, Chen JH. Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical features. Journal of the American Medical Informatics Association : JAMIA. 2025 Sep 22 DOI: 10.1093/jamia/ocaf157.
  11. Incze MA, Huebler S, Baylis JD, Stofko A, Kelley AT, Binswanger IA, Bart G, Saxon AJ, Manhapra A, Gordon AJ. Factors associated with mortality following hospitalization among veterans with opioid use disorder. Journal of substance use and addiction treatment. 2025 Aug 25; 209797, DOI: 10.1016/j.josat.2025.209797.
  12. Bell JS, Tillson M, Anvari MS, Blonigen DM, McGovern M, Magidson JF. Implementation Factors Influencing Peer-Delivered Behavioral Evidence-Based Interventions for Substance Use Disorders: A Scoping Review. Administration and policy in mental health. 2025 Aug 21 DOI: 10.1007/s10488-025-01470-x.
  13. Crasta D, McKee GB, Caulfield NM, Usman H, Trabold N, Crane CA, Funderburk JS, Iverson KM, McDonald SD. Maintaining relationship safety while promoting relationship health: Family service referrals among veterans screened for intimate partner violence. Psychological Services. 2025 Aug 21 DOI: 10.1037/ser0000990.
  14. Stevenson B. Letter to the Editor-Betancourt et al. (2022). [Letter to the Editor]. Military medicine. 2025 Aug 5 DOI: doi.org/10.1093/milmed/usaf370.
  15. Bruzios K, Shaffer PM, Blonigen DM, Cucciare MA, Andre M, Byrne T, Smith J, Smelson D. Intervention for Justice-Involved Homeless Veterans With Co-Occurring Substance Use and Mental Health Disorders: Protocol for a Randomized Controlled Hybrid Effectiveness-Implementation Trial. JMIR research protocols. 2025 Jul 18; 14:e70750, DOI: 10.2196/70750.
  16. Somohano VC, Vasquez AE, Kaplan JB, Robinson CSH. Editorial: Mindfulness-based interventions for substance use disorders among minoritized populations. [Editorial]. Frontiers in psychology. 2025 Jul 17; 16(0):1625381, DOI: 10.3389/fpsyg.2025.1625381.
  17. Pope E, Ameral V, Falcón A, Smith J, Shoemaker-Hunt SJ, Bounthavong M, McCullough M, Kim B. Knowledge and attitudes regarding substance use disorder treatment and harm reduction practices among US pharmacists: A scoping review. Journal of the American Pharmacists Association : JAPhA. 2025 Jun 19; 65(5):102462, DOI: 10.1016/j.japh.2025.102462.
  18. Incze MA, Anderson T, Hansen AM, Szczotka K, Stolebarger L, Tuckett S, Fox S, Bell C, Galyean P, Babbel D, Zickmund S. "They Don't Just Need a Handshake or a Handoff, They Need a Hug": A Qualitative Assessment of the Care Transition Experience of Patients with Substance Use Disorders After Hospital Discharge. Journal of general internal medicine. 2025 Sep 1; 40(13):3023-3033, DOI: 10.1007/s11606-025-09614-3.
  19. Kuhn E, Sayers S, Zimmerman L, Mackintosh MA, Owen JE, Rosen CS, Meis LA, Hagedorn HJ, Erbes CR. Promoting mental health treatment initiation of veterans with PTSD using internet-based family training and telephone coaching: Protocol for a randomized controlled trial. Contemporary clinical trials. 2025 Jul 1; 154:107929, DOI: 10.1016/j.cct.2025.107929.
  20. Kehle-Forbes SM, Davis BC, Williams A, Christ N. Delivering CPT in the Context of Substance Use Disorders; In T. Galovski & J. Wachen (Ed.), Cognitive Processing Therapy for Complex Cases: Evidence-based Strategies. CBT: Science Into Practice (CBT). 2025 Apr 29; 95-114, DOI: https://doi.org/10.1007/978-3-031-87356-0_5.
  21. Webermann AR, Coppola EC, Lazar C, Rosen MI, Murdoch M, Portnoy GA, Black AC. Association of psychiatric diagnoses and military sexual trauma type with denied posttraumatic stress disorder service connection. Journal of affective disorders. 2025 Jul 15; 381:69-76, DOI: 10.1016/j.jad.2025.03.171.
  22. Larsen JR, Zheng C, La J, Wu JT, Kelley M, Gaziano JM, Brophy M, Do NV, Kim DH, Driver JA, DuMontier C, Fillmore NR. Multimorbidity and Its Impact in Older U.S. Veterans Newly Treated for Advanced Non-Small Cell Lung Cancer. Annals of the American Thoracic Society. 2025 Apr 1; 22(4):598-608, DOI: 10.1513/AnnalsATS.202406-587OC.
  23. Banducci AN, Mandavia AD, Bovin MJ, Adams RS, Maloney MA, Roth CE, McClain L, Livingston NA. Opioid overdose, suicide mortality, and premature death among veterans with alcohol or opioid use disorders: The impact of military sexual trauma. Addictive Behaviors. 2025 Aug 1; 167:108330, DOI: 10.1016/j.addbeh.2025.108330.
  24. Mandavia AD, Banducci AN, Simpson TL, Marx BP, Hawn SE, Hyde J, Ameral VE, Sistad Hall RE, Roth CE, Sarpong AA, Davenport M, Meng F, Stein MD, Livingston NA. Sex Differences in Suicide, Lethal Means, and Years of Potential Life Lost Among Veterans With Substance Use Disorder. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2025 Mar 19; 35(3):196-204, DOI: 10.1016/j.whi.2025.02.002.
  25. Blanchard BE, Austin EJ, Chase E, Rouvere J, Sharma V, Johnson M, Sams N, Williams F, Frost MC, Leyde S, Tsui JI, Collins SE, Fortney JC. Primary Care Patient and Clinician Perspectives on Safer Use Strategies for Opioids and/or Stimulants: A Mixed-Method Study. Journal of general internal medicine. 2025 Sep 1; 40(12):2953-2961, DOI: 10.1007/s11606-025-09418-5.
  26. Bernstein EY, Fu CX, Ayanian JZ, Curto VE, Anderson TS, Landon BE. Association of Medicare Advantage vs Traditional Medicare with Clinical Outcomes Among Patients Hospitalized for Substance Use Disorders. Journal of general internal medicine. 2025 Sep 1; 40(12):2964-2972, DOI: 10.1007/s11606-025-09413-w.
  27. Van Doren N, Chang FH, Nguyen A, McKenna KR, Satre DD, Wiltsey-Stirman S. A pilot study of twice-weekly group-based written exposure therapy for veterans in residential substance use treatment: effects on PTSD and depressive symptoms. Addiction science & clinical practice. 2025 Feb 10; 20(1):11, DOI: 10.1186/s13722-024-00531-0.
  28. Lovejoy TI, Wu TY, Maloy P, McPherson SM, Smith CL, Zaccari B. Collaborative Tele-Pain and Substance Use Disorder Care for Patients in a Rural Setting: Results of a Single-Arm Open-Label Pilot Trial. Pain Management Nursing : Official Journal of The American Society of Pain Management Nurses. 2025 Jun 1; 26(3):264-270, DOI: 10.1016/j.pmn.2024.12.020.
  29. Panadero TJ, Gabrielian S, Seamans MJ, Gelberg L, Tsai J, Harris T. Addressing racial and ethnic disparities in premature exits from permanent supportive housing among residents with substance use disorders. BMC public health. 2025 Jan 28; 25(1):355, DOI: 10.1186/s12889-024-21169-2.
  30. Flike K, Naughton E, Bouchard-Bihr R, Tague A, Willwerth G, Nault M, Hyde J. Using What Matters Most to improve health care delivery for individuals and populations of veterans experiencing homelessness and substance use disorders. Explore (New York, N.Y.). 2025 Jan 1; 21(1):103109, DOI: 10.1016/j.explore.2024.103109.
  31. Bertucci S, Schultz E, Stevenson B, Fu SS. An Opt-out Tobacco Treatment Group Intervention Within an Intensive Substance Use Disorders Treatment Program: Initial Outcomes in the Veterans Health Administration. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2024 Dec 23; 27(1):12-17.
  32. Palazzo L, Dorsey CN, Mogk J, Beatty T, King D, Stefanik-Guizlo K, Key D, Matson TE, Shea M, Caldeiro RM, McWethy AG, Wong ES, Idu AE, Glass JE. Formative evaluation of the implementation of digital therapeutics for opioids and other substance use disorders in primary care (DIGITS trial). Implementation research and practice. 2024 Dec 12; 5:26334895241301670, DOI: 10.1177/26334895241301670.
  33. Lee CA, Ilgen MA, Coughlin LN. Racial-Ethnic Differences in Lack of Treatment Among Care-Seeking People With Substance Use Disorders. Psychiatric services (Washington, D.C.). 2025 Jan 1; 76(1):93-94, DOI: 10.1176/appi.ps.20240159.
  34. Nelson RE, Chapman A, Byrne T, Chaiyakunapruk N, Suo Y, Effiong A, Pettey W, Gelberg L, Kertesz SG, Tsai J, Montgomery AE. Cost-Effectiveness of Temporary Financial Assistance for Veterans Experiencing Housing Instability. JAMA Network Open. 2024 Nov 4; 7(11):e2443396, DOI: 10.1001/jamanetworkopen.2024.43396.
  35. Ilonze OJ, Forman DE, LeMond L, Myers J, Hummel S, Vest AR, DeFilippis EM, Habib E, Goodlin SJ. Beyond Guideline-Directed Medical Therapy: Nonpharmacologic Management for Patients With Heart Failure. JACC. Heart failure. 2025 Feb 1; 13(2):185-199, DOI: 10.1016/j.jchf.2024.08.018.
  36. Vest N, Flesaker M, Bohler R, Timko C, Kelly J, Stein M, Humphreys K. Characterizing Collegiate Recovery Programs in the United States and Canada: A Survey of Program Directors. Journal of studies on alcohol and drugs. 2025 Jul 1; 86(4):633-640, DOI: 10.15288/jsad.24-00207.
  37. Liu SA, Brown TR, King AA, Lin LA, Rehman SS, Grucza RA, Xu KY. Opioid-related emergency admissions in people with opioid dependence/use disorder with and without sickle cell disease: An analysis of multi-state insurance claims. General hospital psychiatry. 2024 Sep 24; 91:83-88.
  38. Eisman AB, Palinkas LA, Koffkey C, Lafta H, Fridline J, Harvey C, Kilbourne AM. Building on Strong Foundations: Deploying Enhanced Replicating Effective Programs for evidence-based prevention curriculum adaptation. Translational behavioral medicine. 2024 Sep 3; 14(9):537-548.
  39. Incze MA, Huebler S, Szczotka K, Grant S, Kertesz SG, Gordon AJ. Expert Panel Consensus on the Effectiveness and Implementation of Models to Support Posthospitalization Care Transitions for People With Substance Use Disorders. Journal of addiction medicine. 2024 Nov 1; 18(6):696-704, DOI: 10.1097/ADM.0000000000001369.
  40. Soyer EM, McGinnis KA, Justice AC, Hsieh E, Rodriguez-Barradas MC, Williams EC, Park LS. COVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration. AIDS and behavior. 2024 Jul 24.
  41. Alpert E, Kaplan A, Nelson D, Oslin DW, Polusny MA, Ingram EP, Kehle-Forbes SM. Clusters Based on Within-Treatment Symptom Trajectories as Predictors of Dropout in Treatment for Posttraumatic Stress Disorder and Substance Use Disorder. Journal of Dual Diagnosis. 2024 Jun 6; 1-21.
  42. van Draanen J, Peng J, Ye T, Williams EC, Hill HD, Rowhani-Rahbar A. No change in substance use disorders or overdose after implementation of state Earned Income Tax Credit (EITC). Drug and Alcohol Dependence. 2024 Jul 1; 260:111344.
  43. Lindsey AC, Deem-Bolton C, Finley E, Potter JS, Lanham H, Fleming S. Leveraging Project ECHO to Implement a Suite of Substance Use Learning Communities for Statewide Impact. Substance use & addiction journal. 2024 Oct 1; 45(4):690-697.
  44. Coughlin LN, Zhang L, Frost MC, Khazanov G, McKay JR, DePhilippis D, Lin LA. Contingency management for substance use disorders in the U.S. Veterans Health Administration: 2018-2022. Journal of substance use and addiction treatment. 2024 Aug 1; 163:209400.
  45. Incze MA, Huebler S, Grant S, Gordon AJ. Using the Delphi Process to Prioritize an Agenda for Care Transition Research for Patients With Substance Use Disorders. Substance use & addiction journal. 2024 Jul 1; 45(3):523-528.
  46. Britton PC, Bohnert KM, Denneson LM, Ganoczy D, Ilgen MA. Psychiatric diagnoses, somatic disorders, and emergency dispatches among individuals who used a national suicide crisis line. Journal of psychiatric research. 2024 Jun 1; 174:114-120.
  47. Hwong AR, Barry LC, Li Y, Byers AL. Comorbidities, healthcare use, and contact with healthcare transition services in older veterans after incarceration. Journal of the American Geriatrics Society. 2024 Jun 1; 72(6):1847-1855.
  48. Beck DC, Tabb K, Tilea A, Vance AJ, Hall S, Schroeder A, Zivin K. Diagnosed behavioral health conditions during the perinatal period among a commercially insured population by race/ethnicity, 2008-2020. Frontiers in public health. 2024 Mar 7; 12:1345442.
  49. Toikumo S, Vickers-Smith R, Jinwala Z, Xu H, Saini D, Hartwell EE, Pavicic M, Sullivan KA, Xu K, Jacobson DA, Gelernter J, Rentsch CT, Million Veteran Program, Stahl E, Cheatle M, Zhou H, Waxman SG, Justice AC, Kember RL, Kranzler HR. A multi-ancestry genetic study of pain intensity in 598,339 veterans. Nature medicine. 2024 Apr 1; 30(4):1075-1084.
  50. Incze MA, Kelley AT, James H, Nolan S, Stofko A, Fordham C, Gordon AJ. Post-hospitalization Care Transition Strategies for Patients with Substance Use Disorders: A Narrative Review and Taxonomy. Journal of general internal medicine. 2024 Apr 1; 39(5):837-846.
  51. Van Doren N, Ng H, Rawat E, McKenna KR, Blonigen DM. Virtual reality mindfulness training for veterans in residential substance use treatment: Pilot study of feasibility and acceptability. Journal of substance use and addiction treatment. 2024 Jun 1; 161:209315.
  52. Lee CA, Bonar EE, Ilgen MA. Impact of social determinants of health and individual characteristics on substance use disorder treatment utilization among emerging adults aged 18-25. Addiction research & theory. 2024 Feb 12; 33(1):65-71, DOI: 10.1080/16066359.2024.2314049.
  53. Hawkins EJ, Malte CA, Hagedorn HJ, Gordon AJ, Williams EC, Trim RS, Blanchard BE, Lott A, Danner AN, Saxon AJ. Buprenorphine Receipt and Retention for Opioid Use Disorder Following an Initiative to Increase Access in Primary Care. Journal of addiction medicine. 2024 May 1; 18(3):240-247.
  54. Takada S, Seamans MJ, Javanbakht M, Bone C, Ijadi-Maghsoodi R, Shoptaw S, Gelberg L. Nativity and the risk of opioid use disorder among Hispanic/Latinx women in primary care in Los Angeles, CA. Journal of ethnicity in substance abuse. 2024 Feb 7; 1-15.
  55. Barr PB, Bigdeli TB, Meyers JL, Peterson RE, Sanchez-Roige S, Mallard TT, Dick DM, Harden KP, Wilkinson A, Graham DP, Nielsen DA, Swann AC, Lipsky RK, Kosten TR, Aslan M, Harvey PD, Kimbrel NA, Beckham JC, Million Veteran Program (MVP)Cooperative Studies Program & #x28;CSP) #572. Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program Cohort. JAMA psychiatry. 2024 Feb 1; 81(2):188-197.
  56. Richardson C, Daniels K, Confer A, Saxon AJ, Gordon AJ, Liberto J, Albanese AP, Renner J, Edens E, Kennedy AJ. Internal Medicine Resident Addiction Training at the Veteran's Health Administration: A Qualitative Evaluation of Site Directors' Response to the 2022 ACGME Requirements. Journal of general internal medicine. 2024 Jun 1; 39(8):1393-1399.
  57. Rollins AL, Eliacin J, Kukla ME, Wasmuth S, Salyers MP, McGuire AB. Implementation of Integrated Dual Disorder Treatment in Routine Veterans Health Administration Settings. International journal of mental health and addiction. 2024 Feb 1; 22:578-598.
  58. Hallgren KA, Matson TE, Oliver M, Wang X, Williams EC, Bradley KA. Test-retest reliability of DSM-5 substance use symptom checklists used in primary care and mental health care settings. Drug and Alcohol Dependence. 2024 Mar 1; 256:111108.
  59. Watson DP, Swartz JA, Magee LA, Bray BC, Phalen P, Medcalf S, McGuire AB. Latent class analysis of emergency department patients engaged in telehealth peer recovery support services and associations of identified classes with post-discharge outcomes. Journal of substance use and addiction treatment. 2024 May 1; 160:209282.
  60. Scheibein F, Caballeria E, Taher MA, Arya S, Bancroft A, Dannatt L, De Kock C, Chaudhary NI, Gayo RP, Ghosh A, Gelberg L, Goos C, Gordon R, Gual A, Hill P, Jeziorska I, Kurcevic E, Lakhov A, Maharjan I, Matrai S, Morgan N, Paraskevopoulos I, Puharic Z, Sibeko G, Stola J, Tiburcio M, Tay Wee Teck J, Tsereteli Z, López-Pe layo H. Optimizing Digital Tools for the Field of Substance Use and Substance Use Disorders: Backcasting Exercise. JMIR human factors. 2023 Dec 12; 10:e46678.
  61. Roncarati JS, DeVone F, Halladay C, Tsai J, Jutkowitz E. Risk of dementia among veterans experiencing homelessness and housing instability. Journal of the American Geriatrics Society. 2024 Feb 1; 72(2):382-389.
  62. Ebrahimi R, Dennis PA, Shroyer ALW, Tseng CH, Alvarez CA, Beckham JC, Sumner JA. Pathways Linking Post-Traumatic Stress Disorder to Incident Ischemic Heart Disease in Women: Call to Action. JACC. Advances. 2024 Jan 1; 3(1):100744.
  63. Shuey B, Suda KJ, Halbisen A, Wen H, Wharam JF, Rosland AM, Liebschutz JM. Anti-hypertensive Medication Use Among People with and without Substance Use Disorders. Journal of general internal medicine. 2024 Feb 1; 39(3):508-510.
  64. Percy A, Kelley AT, Valentino N, Butz A, Baylis JD, Suo Y, Gordon AJ, Jones AL. Care Practices of Mental Health Clinical Pharmacist Practitioners Within an Interdisciplinary Primary Care Model for Patients With Substance Use Disorders. Substance Abuse. 2023 Oct 1; 44(4):330-336.
  65. Hutchins F, Rosland AM, Zhao X, Zhang H, Thorpe JM. The impact of dual VA-Medicare use on a data-driven clinical management tool for older Veterans with multimorbidity. Journal of the American Geriatrics Society. 2024 Jan 1; 72(1):69-79.
  66. Frost MC, Malte CA, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders. Journal of substance use and addiction treatment. 2023 Sep 24; 209175.
  67. Pfeiffer PN, Ganoczy D, Zivin K, Gerlach L, Damschroder L, Ulmer CS. Guideline-concordant use of cognitive behavioral therapy for insomnia in the Veterans Health Administration. Sleep health. 2023 Dec 1; 9(6):893-896.
  68. Faltushanskiy Z, Herrold AA, Werby J, Betteridge EM, Angres D. Personality predicting relapse: A facet analysis of the NEO PI-R. The American journal on addictions. 2024 Jan 1; 33(1):58-64.
  69. Blanchard BE, Lynch KG, Malte CA, Hawkins EJ, DePhilippis D, Oslin DW, McKay JR, Saxon AJ. Towards shortening the Brief Addiction Monitor-Revised (BAM-R). Drug and Alcohol Dependence Reports. 2023 Sep 1; 8:100183.
  70. Cameron D, Shiner B, O'Neill A, O&#x 27;Neil M. Factors Associated with Engaging in Evidence-Based Psychotherapy During the First Year of Posttraumatic Stress Disorder Treatment Between 2017 and 2019. Administration and policy in mental health. 2023 Sep 1; 50(5):813-823.
  71. Pogoda TK, Adams RS, Carlson KF, Dismuke-Greer CE, Amuan M, Pugh MJ. Risk of Adverse Outcomes Among Veterans Who Screen Positive for Traumatic Brain Injury in the Veterans Health Administration But Do Not Complete a Comprehensive Evaluation: A LIMBIC-CENC Study. The Journal of head trauma rehabilitation. 2024 May 1; 39(3):171-182.
  72. Woodhead EL, Ilgen M, Timko C. Telephone monitoring and 15-month outcomes for patients with co-occurring substance use and mental health disorders: Moderating effects of high-risk patient characteristics. Journal of substance use and addiction treatment. 2023 Sep 1; 152:209094.
  73. Han BH, Bronson J, Washington L, Yu M, Kelton K, Tsai J, Finlay AK. Co-occurring Medical Multimorbidity, Mental Illness, and Substance Use Disorders Among Older Criminal Legal System-Involved Veterans. Medical care. 2023 Jul 1; 61(7):477-483.
  74. Gujral K, Van Campen J, Jacobs J, Kimerling R, Zulman DM, Blonigen D. Impact of VA's video telehealth tablets on substance use disorder care during the COVID-19 pandemic. Journal of substance use and addiction treatment. 2023 Jul 1; 150:209067.
  75. Frost MC, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Associations Between Distinct Co-occurring Substance Use Disorders and Receipt of Medications for Opioid Use Disorder in the Veterans Health Administration. Journal of addiction medicine. 2023 May 1; 17(3):278-285.
  76. Matson TE, Hallgren KA, Lapham GT, Oliver M, Wang X, Williams EC, Bradley KA. Psychometric Performance of a Substance Use Symptom Checklist to Help Clinicians Assess Substance Use Disorder in Primary Care. JAMA Network Open. 2023 May 1; 6(5):e2316283.
  77. Tsai J, Szymkowiak D, Zullig LL. Epidemiology and Psychiatric Correlates of Cancer among Homeless and Unstably Housed Veterans in the VA Health Care System. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2023 May 1; 32(5):617-624.
  78. Gao YA, Krans EE, Chen Q, Rothenberger SD, Zivin K, Jarlenski MP. Sex-related differences in the prevalence of substance use disorders, treatment, and overdose among parents with young children. Addictive behaviors reports. 2023 Jun 1; 17:100492.
  79. Fast N, van Kessel R, Humphreys K, Ward NF, Roman-Urrestarazu A. The Evolution of Telepsychiatry for Substance Use Disorders During COVID-19: a Narrative Review. Current addiction reports. 2023 Apr 25; 10(2):187-197.
  80. Dhinsa J, Roman-Urrestarazu A, van Kessel R, Humphreys K. Understanding predictors of mental health and substance use treatment utilization among US adults: A repeated cross-sectional study. Global epidemiology. 2023 Dec 1; 5:100109.
  81. Zaman T, Bravata DM, Byers AL, Krebs EE, Leonard SJ, Sandbrink F, Barker W, Keyhani S. A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care. BMC psychiatry. 2023 Mar 17; 23(1):177.
  82. Ward RN, Erickson AJ, Carlson KJ, Yalch MM. The role of unit cohesion and perceived resilience in substance use disorder. Military psychology : the official journal of the Division of Military Psychology, American Psychological Association. 2024 Jul 3; 36(4):403-409.
  83. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients. The Clinical Journal of Pain. 2023 Mar 1; 39(3):107-118.
  84. Lowell AF, DeCoste C, Dalton R, Dias H, Borelli JL, Martino S, McMahon TJ, Suchman NE. Mothering from the Inside Out: Results of a community-based randomized efficacy trial testing a mentalization-based parenting intervention for mothers with addictions. Infant mental health journal. 2023 Mar 1; 44(2):142-165.
  85. Ward MJ, Hwang U, Hastings SN, Timko C, Chen JI, Vashi AA, Mattocks K, Abel EA, Bravata DM. Research and policy recommendations from the SOTA XVI: State of the Art Conference on VA Emergency Medicine. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2023 Apr 1; 30(4):240-251.
  86. Jones AL, Chu K, Rose DE, Gelberg L, Kertesz SG, Gordon AJ, Wells KB, Leung L. Quality of Depression Care for Veterans Affairs Primary Care Patients with Experiences of Homelessness. Journal of general internal medicine. 2023 Aug 1; 38(11):2436-2444.
  87. Shirley K, O'Neil M, Boyd S, Lofti s JM. Differences in rates of impairment in adults who use methamphetamine using two sets of demographically corrected norms. Applied neuropsychology. Adult. 2023 Jan 20; 1-9.
  88. Denneson LM, Cameron DC, Hooker ER, Laliberte AZ, Chen JI. Self-Directed Violence Surveillance in the Veterans Health Administration: A National Examination of Factors Associated with Undetermined Versus Suicide Attempt Classification. Community mental health journal. 2023 Jul 1; 59(5):954-961.
  89. Lin C, Pham H, Zhu Y, Clingan SE, Lin LA, Murphy SM, Campbell CI, Sorrell TR, Liu Y, Mooney LJ, Hser YI. Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States. Drug and Alcohol Dependence. 2023 Jan 1; 242:109711.
  90. Hutchins F, Thorpe J, Zhao X, Zhang H, Rosland AM. Two-year change in latent classes of comorbidity among high-risk Veterans in primary care: a brief report. BMC health services research. 2022 Nov 12; 22(1):1341.
  91. Hyde J, Byrne T, Petrakis BA, Yakovchenko V, Kim B, Fincke G, Bolton R, Visher C, Blue-Howells J, Drainoni ML, McInnes DK. Enhancing community integration after incarceration: findings from a prospective study of an intensive peer support intervention for veterans with an historical comparison group. Health & justice. 2022 Nov 8; 10(1):33.
  92. Mackey KM, Anderson JK, Williams BE, Ward RM, Parr NJ. Evidence Brief: Psychedelic Medications for Mental Health and Substance Use Disorders. Evidence Synthesis Program, Health Services Research and Development Service. Washington, DC: Office of Research and Development, Department of Veterans Affairs; 2022 Oct 1. 45 p. Report No.: VA ESP Project #09-199.
  93. Kember RL, Vickers-Smith R, Xu H, Toikumo S, Niarchou M, Zhou H, Hartwell EE, Crist RC, Rentsch CT, Million Veteran Program, Davis LK, Justice AC, Sanchez-Roige S, Kampman KM, Gelernter J, Kranzler HR. Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction. Nature neuroscience. 2022 Oct 1; 25(10):1279-1287.
  94. Carlson KF, Gilbert TA, DeFrancesco S, Wright DA, Shen X, Cook LJ. Accuracy of behavioral health variables in Oregon national violent death reporting system data: a linked cohort study. Injury epidemiology. 2022 Sep 13; 9(1):29.
  95. Galovski TE, Street AE, Creech S, Lehavot K, Kelly UA, Yano EM. State of the Knowledge of VA Military Sexual Trauma Research. Journal of general internal medicine. 2022 Sep 1; 37(Suppl 3):825-832.
  96. Gibson CJ, Li Y, Jasuja GK, Keyhani S, Byers AL. Long-term Psychoactive Medications, Polypharmacy, and Risk of Suicide and Unintended Overdose Death Among Midlife and Older Women Veterans. Journal of general internal medicine. 2022 Sep 1; 37(Suppl 3):770-777.
  97. Riggs KR, DeRussy AJ, Leisch L, Shover CL, Bohnert ASB, Hoge AE, Montgomery AE, Varley AL, Jones AL, Gordon AJ, Kertesz SG. Sensitivity of health records for self-reported nonfatal drug and alcohol overdose. The American journal on addictions. 2022 Nov 1; 31(6):517-522.
  98. Kehle-Forbes SM, Nelson D, Norman SB, Schnurr PP, Shea MT, Ackland PE, Meis L, Possemato K, Polusny MA, Oslin D, Hamblen JL, Galovski T, Kenny M, Babajide N, Hagedorn H. Comparative effectiveness of trauma-focused and non-trauma-focused psychotherapy for PTSD among veterans with comorbid substance use disorders: Protocol & rationale for a randomized clinical trial. Contemporary clinical trials. 2022 Sep 1; 120:106876.
  99. Deak JD, Zhou H, Galimberti M, Levey DF, Wendt FR, Sanchez-Roige S, Hatoum AS, Johnson EC, Nunez YZ, Demontis D, Børglum AD, Rajagopal VM, Jennings MV, Kember RL, Justice AC, Edenberg HJ, Agrawal A, Polimanti R, Kranzler HR, Geler nter J. Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci. Molecular Psychiatry. 2022 Oct 1; 27(10):3970-3979.
  100. Varley AL, Hoge A, Riggs KR, deRussy A, Jones AL, Austin EL, Gabrielian S, Gelberg L, Gordon AJ, Blosnich JR, Montgomery AE, Kertesz SG. What do Veterans with homeless experience want us to know that we are not asking? A qualitative content analysis of comments from a national survey of healthcare experience. Health & Social Care in The Community. 2022 Nov 1; 30(6):e5027-e5037.
  101. Powell VD, Macleod C, Sussman J, Lin LA, Bohnert ASB, Lagisetty P. Variation in Clinical Characteristics and Longitudinal Outcomes in Individuals with Opioid Use Disorder Diagnosis Codes. Journal of general internal medicine. 2023 Feb 1; 38(3):699-706.
  102. Hayes CJ, Koonce RM, Gressler LE, Hu B, Williams JS, Martin BC. Association between opioid therapy trajectories and potential opioid-related adverse health events. Pharmacoepidemiology and drug safety. 2022 Oct 1; 31(10):1075-1090.
  103. Fletcher OV, Chen JA, van Draanen J, Frost MC, Rubinsky AD, Blosnich JR, Williams EC. Prevalence of social and economic stressors among transgender veterans with alcohol and other drug use disorders. SSM - population health. 2022 Sep 1; 19:101153.
  104. Williams EC, Fletcher OV, Frost MC, Harris AHS, Washington DL, Hoggatt KJ. Comparison of Substance Use Disorder Diagnosis Rates From Electronic Health Record Data With Substance Use Disorder Prevalence Rates Reported in Surveys Across Sociodemographic Groups in the Veterans Health Administration. JAMA Network Open. 2022 Jun 1; 5(6):e2219651.
  105. Timko C, Hoggatt KJ, Esmaeili A, Lewis E, Lor MC, Maust DT, Nevedal AL. Long-Term Benzodiazepine Use and Discontinuation Among Patients in the U.S. Veterans Health Administration. Psychiatric services (Washington, D.C.). 2022 Nov 1; 73(11):1217-1224.
  106. Copeland LA, Pugh MJ, Bollinger MJ, Wang CP, Amuan ME, Rivera JC, Shireman PK. The VA vascular injury study: A glimpse at quality of care in Veterans with traumatic vascular injury repair. Injury. 2022 Jun 1; 53(6):1947-1953.
  107. Perry C, Liberto J, Milliken C, Burden J, Hagedorn H, Atkinson T, McKay JR, Mooney L, Sall J, Sasson C, Saxon A, Spevak C, Gordon AJ, VA/DoD Guideline Development G roup. The Management of Substance Use Disorders: Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Annals of internal medicine. 2022 May 1; 175(5):720-731.
  108. Giannitrapani KF, Holliday JR, Dawson AW, Huynh AK, Hamilton AB, Timko C, Hoggatt KJ. Provider perceptions of challenges to identifying women Veterans with hazardous substance use. BMC health services research. 2022 Mar 4; 22(1):300.
  109. Hasin DS, Fink DS, Olfson M, Saxon AJ, Malte C, Keyes KM, Gradus JL, Cerdá M, Maynard CC, Keyhani S, Martins SS, Livne O, Mannes ZL, Sherman SE, W all MM. Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records. Drug and Alcohol Dependence. 2022 May 1; 234:109383.
  110. Billig JI, Gunaseelan V, Yazdanfar M, Sears ED, Iwashyna TJ, Chang T, Waljee JF. Gabapentinoid Prescribing for Carpal Tunnel Syndrome. Hand (New York, N.Y.). 2023 Jan 1; 18(1_suppl):106S-113S.
  111. Ameral V, Hocking E, Leviyah X, Newberger NG, Timko C, Livingston N. Innovating for real-world care: A systematic review of interventions to improve post-detoxification outcomes for opioid use disorder. Drug and Alcohol Dependence. 2022 Apr 1; 233:109379.
  112. Jones AL, Kelley AT, Suo Y, Baylis JD, Codell NK, West NA, Gordon AJ. Trends in Health Service Utilization After Enrollment in an Interdisciplinary Primary Care Clinic for Veterans with Addiction, Social Determinants of Health, or Other Vulnerabilities. Journal of general internal medicine. 2023 Jan 1; 38(1):12-20.
  113. Schmidt EM, Liu P, Combs A, Trafton J, Asch S, Harris AHS. Surveying the Landscape of Quality-of-Care Measures for Mental and Substance Use Disorders. Psychiatric services (Washington, D.C.). 2022 Aug 1; 73(8):880-888.
  114. Self KJ, Borsari B, Ladd BO, Nicolas G, Gibson CJ, Jackson K, Manuel JK. Cultural adaptations of motivational interviewing: A systematic review. Psychological Services. 2022 Feb 7; 20(Suppl 1):7-18, DOI: 10.1037/ser0000619.
  115. Arnold J, Thorpe J, Mains-Mason J, Rosland AM. Empiric segmentation of high-risk patients: a structured literature review. The American journal of managed care. 2022 Feb 1; 28(2):e69-e77.
  116. Livingston NA, Lynch KE, Hinds Z, Gatsby E, DuVall SL, Shipherd JC. Identifying Posttraumatic Stress Disorder and Disparity Among Transgender Veterans Using Nationwide Veterans Health Administration Electronic Health Record Data. LGBT health. 2022 Jan 4; 9(2):94-102.
  117. Blakey SM, Campbell SB, Simpson TL. Associations Between Lifetime Panic Attacks, Posttraumatic Stress Disorder, and Substance Use Disorders in a Nationally Representative Sample. Journal of Dual Diagnosis. 2022 Jan 1; 18(1):21-32.
  118. Hayes CJ, Krebs EE, Brown J, Li C, Hudson T, Martin BC. Impact of transitioning from long-term to intermittent opioid therapy on the development of opioid-related adverse outcomes: A retrospective cohort study. Drug and Alcohol Dependence. 2022 Feb 1; 231:109236.
  119. Ogden SN, Dichter ME, Bazzi AR. Intimate partner violence as a predictor of substance use outcomes among women: A systematic review. Addictive Behaviors. 2022 Apr 1; 127:107214.
  120. Potter JS, Finley EP, King VL, Lanham HJ, Schmidt S, Schneegans S, Rosen KD. Adapting and scaling a single site DEA X-waiver training program to a statewide initiative: Implementing GetWaiveredTX. Journal of substance abuse treatment. 2022 Jun 1; 137:108688.
  121. Khouja T, Zhou J, Gellad WF, Mitsantisuk K, Hubbard CC, Yan CH, Sharp LK, Calip GS, Evans CT, Suda KJ. Serious opioid-related adverse outcomes associated with opioids prescribed by dentists. Pain. 2022 Aug 1; 163(8):1571-1580.
  122. Hatoum AS, Johnson EC, Colbert SMC, Polimanti R, Zhou H, Walters RK, Gelernter J, Edenberg HJ, Bogdan R, Agrawal A. The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2022 Sep 1; 47(10):1739-1745.
  123. Hutchins F, Thorpe J, Maciejewski ML, Zhao X, Daniels K, Zhang H, Zulman DM, Fihn S, Vijan S, Rosland AM. Clinical Outcome and Utilization Profiles Among Latent Groups of High-Risk Patients: Moving from Segmentation Towards Intervention. Journal of general internal medicine. 2022 Aug 1; 37(10):2429-2437.
  124. Jones AL, Gelberg L, deRussy AJ, Varley AL, Riggs KR, Gordon AJ, Kertesz SG. Low Uptake of Secure Messaging Among Veterans With Experiences of Homelessness and Substance Use Disorders. Journal of addiction medicine. 2021 Nov 1; 15(6):508-511.
  125. Leung LB, Benitez CT, Dorsey C, Mahajan AP, Hellemann GS, Whelan F, Park NJ, Braslow JT. Integrating Mental Health in Safety-net Primary Care: A Five-year Observational Study on Visits in a County Health System. Medical care. 2021 Nov 1; 59(11):975-979.
  126. Scott JC, Lynch KG, Cenkner DP, Kehle-Forbes SM, Polusny MA, Gur RC, Chen S, Foa EB, Oslin DW. Neurocognitive predictors of treatment outcomes in psychotherapy for comorbid PTSD and substance use disorders. Journal of consulting and clinical psychology. 2021 Nov 1; 89(11):937-946.
  127. Hayes CJ, Krebs EE, Li C, Brown J, Hudson T, Martin BC. Association between discontinuing chronic opioid therapy and newly diagnosed substance use disorders, accidents, self-inflicted injuries and drug overdoses within the prescribers' health care system: a retrospective cohort study. Addiction (Abingdon, England). 2022 Apr 1; 117(4):946-968.
  128. Abraham KM, Chang MM, Van T, Resnick SG, Zivin K. Employment After Vocational Rehabilitation Predicts Decreased Health Care Utilization in Veterans With Mental Health Diagnoses. Military medicine. 2021 Aug 28; 186(9-10):850-857.
  129. Frank RG, Humphreys KN, Pollack HA. Policy Responses to the Addiction Crisis. Journal of Health Politics, Policy and Law. 2021 Aug 1; 46(4):585-597.
  130. Magaletta PR, Morasco BJ. Perspectives on opioid misuse from public service psychology: An introduction. Psychological Services. 2021 Aug 1; 18(3):285-286.
  131. Medicaid Outcomes Distributed Research Network (MODRN) , Donohue JM, Jarlenski MP, Kim JY, Tang L, Ahrens K, Allen L, Austin A, Barnes AJ, Burns M, Chang CH, Clark S, Cole E, Crane D, Cunningham P, Idala D, Junker S, Lanier P, Mauk R, McDuffie MJ, Mohamoud S, Pauly N, Sheets L, Talbert J, Zivin K, Gordon AJ, Kennedy S. Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018. JAMA. 2021 Jul 13; 326(2):154-164.
  132. Gelernter J, Polimanti R. Genetics of substance use disorders in the era of big data. Nature reviews. Genetics. 2021 Nov 1; 22(11):712-729.
  133. Núñez ER, Caverly TJ, Zhang S, Glickman ME, Qian SX, Boudreau JH, Slatore CG, Miller DR, Wiener RS. Adherence to Follow-up Testing Recommendations in US Veterans Screened for Lung Cancer, 2015-2019. JAMA Network Open. 2021 Jul 1; 4(7):e2116233.
  134. Rogal S, Youk A, Agbalajobi O, Zhang H, Gellad W, Fine MJ, Belperio P, Morgan T, Good CB, Kraemer K. Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis. The American journal of gastroenterology. 2021 Jul 1; 116(7):1406-1413.
  135. Cox J, Sherva R, Wetherill L, Foroud T, Edenberg HJ, Kranzler HR, Gelernter J, Farrer LA. Genome-wide association study of stimulant dependence. Translational psychiatry. 2021 Jun 29; 11(1):363.
  136. Kelley AT, Smid MC, Baylis JD, Charron E, Binns-Calvey AE, Archer S, Weiner SJ, Begaye LJ, Cochran G. Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities. Addiction science & clinical practice. 2021 Jun 25; 16(1):40.
  137. McGee-Vincent P, Juhasz K, Jamison AL, Avery TJ, Owen JE, Jaworski BK, Blonigen DM. Mobile Mental Health Apps from the National Center for PTSD: Digital Self-Management Tools for Co-Occurring Disorders. Journal of Dual Diagnosis. 2021 Jul 1; 17(3):181-192.
  138. Haffajee RL, Faherty LJ, Zivin K. Pregnant Women with Substance Use Disorders - The Harm Associated with Punitive Approaches. The New England journal of medicine. 2021 Jun 24; 384(25):2364-2367.
  139. Schmidt EM, Wright D, Cherkasova E, Harris AHS, Trafton J. Evaluating and Improving Engagement in Care After High-Intensity Stays for Mental or Substance Use Disorders. Psychiatric services (Washington, D.C.). 2022 Jan 1; 73(1):18-25.
  140. Wong MS, Gabrielian S, Lynch KE, Coronado G, Viernes B, Gelberg L, Taylor SL. Healthcare service utilization for formerly homeless veterans in permanent supportive housing: Do neighborhoods matter?. Psychological Services. 2022 Aug 1; 19(3):471-479.
  141. Macia KS, Blonigen DM, Shaffer PM, Cloitre M, Smelson DA. Trauma-related differences in socio-emotional functioning predict housing and employment outcomes in homeless veterans. Social science & medicine (1982). 2021 Jul 1; 281:114096.
  142. Lei L, Strominger J, Wiechers IR, Kim HM, Blow FC, Bohnert ASB, Min L, Krein SL, Maust DT. Benzodiazepine Prescribing from VA and Medicare to Dually Enrolled Older Veterans: A Retrospective Cohort Study. Journal of general internal medicine. 2021 Dec 1; 36(12):3689-3696.
  143. Goldstone LW, DiPaula BA, Werremeyer A, Botts S, Hepburn B, Liu HY, Duckworth K, Young AS, Kelly DL. The Role of Board-Certified Psychiatric Pharmacists in Expanding Access to Care and Improving Patient Outcomes. Psychiatric services (Washington, D.C.). 2021 Jul 1; 72(7):794-801.
  144. Dillon KH, Van Voorhees EE, Elbogen EB, Beckham JC, VA Mid-Atlantic MIRECC Workgroup, Calhoun PS. Cannabis use disorder, anger, and violence in Iraq/Afghanistan-era veterans. Journal of psychiatric research. 2021 Jun 1; 138:375-379.
  145. Tsai J, Edwards E, Cao X, Finlay AK. Disentangling associations between military service, race, and incarceration in the U.S. population. Psychological Services. 2022 Aug 1; 19(3):431-442.
  146. Santa Ana EJ, LaRowe SD, Gebregziabher M, Morgan-Lopez AA, Lamb K, Beavis KA, Bishu K, Martino S. Randomized controlled trial of group motivational interviewing for veterans with substance use disorders. Drug and Alcohol Dependence. 2021 Jun 1; 223:108716.
  147. Clair K, Ijadi-Maghsoodi R, Nazinyan M, Gabrielian S, Kalofonos I. Veteran Perspectives on Adaptations to a VA Residential Rehabilitation Program for Substance Use Disorders During the Novel Coronavirus Pandemic. Community mental health journal. 2021 Jul 1; 57(5):801-807.
  148. Wyse JJ, Lovejoy J, Holloway J, Morasco BJ, Dobscha SK, Hagedorn H, Lovejoy TI. Patients' perceptions of the pathways linking chronic pain with problematic substance use. Pain. 2021 Mar 1; 162(3):787-793.
  149. Sherva R, Zhu C, Wetherill L, Edenberg HJ, Johnson E, Degenhardt L, Agrawal A, Martin NG, Nelson E, Kranzler HR, Gelernter J, Farrer LA. Genome-wide association study of phenotypes measuring progression from first cocaine or opioid use to dependence reveals novel risk genes. Exploration of medicine. 2021 Feb 28; 2:60-73.
  150. Dargis M, Patrick CJ, Blonigen DM. Relevance of psychopathic traits to therapeutic processes and outcomes for veterans with substance use disorders. Personality disorders. 2022 Jan 1; 13(1):64-74.
  151. Johnson-Kwochka A, Aalsma MC, Monahan PO, Salyers MP. Development and examination of the attribution questionnaire-substance use disorder (AQ-SUD) to measure public stigma towards adolescents experiencing substance use disorders. Drug and Alcohol Dependence. 2021 Apr 1; 221:108600.
  152. Dandachi D, de Groot A, Rajabiun S, Rajashekara S, Davila JA, Quinn E, Cabral HJ, Wilson IB, Giordano TP. Reliability and Validity of a Brief Self-Report Adherence Measure among People with HIV Experiencing Homelessness and Mental Health or Substance Use Disorders. AIDS and behavior. 2021 Feb 1; 25(2):322-329.
  153. Gibson CJ, Li Y, Jasuja GK, Self KJ, Seal KH, Byers AL. Menopausal Hormone Therapy and Suicide in a National Sample of Midlife and Older Women Veterans. Medical care. 2021 Feb 1; 59:S70-S76.
  154. Hughto JMW, Quinn EK, Dunbar MS, Rose AJ, Shireman TI, Jasuja GK. Prevalence and Co-occurrence of Alcohol, Nicotine, and Other Substance Use Disorder Diagnoses Among US Transgender and Cisgender Adults. JAMA Network Open. 2021 Feb 1; 4(2):e2036512.
  155. Rockett IRH, Caine ED, Banerjee A, Ali B, Miller T, Connery HS, Lulla VO, Nolte KB, Larkin GL, Stack S, Hendricks B, McHugh RK, White FMM, Greenfield SF, Bohnert ASB, Cossman JS, D'Onofrio G, Nelson LS, Nestadt PS, Berry JH, J ia H. Fatal self-injury in the United States, 1999-2018: Unmasking a national mental health crisis. EClinicalMedicine. 2021 Feb 1; 32:100741.
  156. Szymanski BR, Hein TC, Schoenbaum M, McCarthy JF, Katz IR. Facility-Level Excess Mortality of VHA Patients With Mental Health or Substance Use Disorder Diagnoses. Psychiatric services (Washington, D.C.). 2021 Apr 1; 72(4):408-414.
  157. Polimanti R, Levey DF, Pathak GA, Wendt FR, Nunez YZ, Ursano RJ, Kessler RC, Kranzler HR, Stein MB, Gelernter J. Multi-environment gene interactions linked to the interplay between polysubstance dependence and suicidality. Translational psychiatry. 2021 Jan 11; 11(1):34.
  158. Doshi R, Dave M, Majmundar M, Kumar A, Adalja D, Shariff M, Desai R, Ziaeian B, Vallabhajosyula S. National rates and trends of tobacco and substance use disorders among atrial fibrillation hospitalizations. Heart & lung : the journal of critical care. 2021 Mar 1; 50(2):244-251.
  159. Codell N, Kelley AT, Jones AL, Dungan MT, Valentino N, Holtey AI, Knight TJ, Butz A, Gallop C, Erickson S, Patton J, Hyte-Richins LJ, Rollins BZ, Gordon AJ. Aims, development, and early results of an interdisciplinary primary care initiative to address patient vulnerabilities. The American journal of drug and alcohol abuse. 2021 Mar 4; 47(2):160-169.
  160. Ilgen MA, Coughlin LN, Bohnert ASB, Chermack S, Price A, Kim HM, Jannausch M, Blow FC. Efficacy of a Psychosocial Pain Management Intervention for Men and Women With Substance Use Disorders and Chronic Pain: A Randomized Clinical Trial. JAMA psychiatry. 2020 Dec 1; 77(12):1225-1234.
  161. Yeung K, Richards J, Goemer E, Lozano P, Lapham G, Williams E, Glass J, Lee A, Achtmeyer C, Caldeiro R, Parrish R, Bradley K. Costs of using evidence-based implementation strategies for behavioral health integration in a large primary care system. Health services research. 2020 Dec 1; 55(6):913-923.
  162. Silverberg MJ, Levine-Hall T, Hood N, Anderson AN, Alexeeff SE, Lam JO, Slome SB, Flamm JA, Hare CB, Ross T, Justice AC, Sterne JAC, Williams AE, Bryant KJ, Weisner CM, Horberg MA, Sterling SA, Satre DD. Health System-Based Unhealthy Alcohol Use Screening and Treatment Comparing Demographically Matched Participants With and Without HIV. Alcoholism, clinical and experimental research. 2020 Dec 1; 44(12):2545-2554.
  163. Becker WC, Krebs EE, Edmond SN, Lin LA, Sullivan MD, Weiss RD, Gordon AJ. A Research Agenda for Advancing Strategies to Improve Opioid Safety: Findings from a VHA State of the Art Conference. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):978-982.
  164. Minegishi T, Garrido MM, Stein M, Oliva EM, Frakt AB. Opioid Discontinuation Among Patients Receiving High-Dose Long-Term Opioid Therapy in the Veterans Health Administration. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):903-909.
  165. Coughlin LN, Pfeiffer P, Ganoczy D, Lin LA. Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder. The American journal of psychiatry. 2021 May 1; 178(5):414-423.
  166. Vest N, Sox-Harris A, Ilgen M, Humphreys K, Timko C. Depression, Alcoholics Anonymous Involvement, and Daily Drinking Among Patients with co-occurring Conditions: A Longitudinal Parallel Growth Mixture Model. Alcoholism, clinical and experimental research. 2020 Dec 1; 44(12):2570-2578.
  167. Johnson EC, Demontis D, Thorgeirsson TE, Walters RK, Polimanti R, Hatoum AS, Sanchez-Roige S, Paul SE, Wendt FR, Clarke TK, Lai D, Reginsson GW, Zhou H, He J, Baranger DAA, Gudbjartsson DF, Wedow R, Adkins DE, Adkins AE, Alexander J, Bacanu SA, Bigdeli TB, Boden J, Brown SA, Bucholz KK, Bybjerg-Grauholm J, Corley RP, Degenhardt L, Dick DM, Domingue BW, Fox L, Goate AM, Gordon SD, Hack LM, Hancock DB, Hartz SM, Hickie IB, Hougaard DM, Krauter K, Lind PA, McClintick JN, McQueen MB, Meyers JL, Montgomery GW, Mors O, Mortensen PB, Nordentoft M, Pearson JF, Peterson RE, Reynolds MD, Rice JP, Runarsdottir V, Saccone NL, Sherva R, Silberg JL, Tarter RE, Tyrfingsson T, Wall TL, Webb BT, Werge T, Wetherill L, Wright MJ, Zellers S, Adams MJ, Bierut LJ, Boardman JD, Copeland WE, Farrer LA, Foroud TM, Gillespie NA, Grucza RA, Harris KM, Heath AC, Hesselbrock V, Hewitt JK, Hopfer CJ, Horwood J, Iacono WG, Johnson EO, Kendler KS, Kennedy MA, Kranzler HR, Madden PAF, Maes HH, Maher BS, Martin NG, McGue M, McIntosh AM, Medland SE, Nelson EC, Porjesz B, Riley BP, Stallings MC, Vanyukov MM, Vrieze S, Psychiatric Genomics Consortium Substance Use Disorders Workgroup, Davis LK, Bogdan R, Gelernter J, Edenberg HJ, Stefansson K, Børglum AD, Agr awal A. A large-scale genome-wide association study meta-analysis of cannabis use disorder. The lancet. Psychiatry. 2020 Dec 1; 7(12):1032-1045.
  168. Johnson-Kwochka A, Dir A, Salyers MP, Aalsma MC. Organizational structure, climate, and collaboration between juvenile justice and community mental health centers: implications for evidence-based practice implementation for adolescent substance use disorder treatment. BMC health services research. 2020 Oct 8; 20(1):929.
  169. Jones AL, Cochran SD, Rafferty J, Taylor RJ, Mays VM. Lifetime and Twelve-Month Prevalence, Persistence, and Unmet Treatment Needs of Mood, Anxiety, and Substance Use Disorders in African American and U.S. versus Foreign-Born Caribbean Women. International journal of environmental research and public health. 2020 Sep 25; 17(19).
  170. Womack JA, Murphy TE, Bathulapalli H, Smith A, Bates J, Jarad S, Redeker NS, Luther SL, Gill TM, Brandt CA, Justice AC. Serious Falls in Middle-Aged Veterans: Development and Validation of a Predictive Risk Model. Journal of the American Geriatrics Society. 2020 Dec 1; 68(12):2847-2854.
  171. Jarlenski M, Krans EE, Chen Q, Rothenberger SD, Cartus A, Zivin K, Bodnar LM. Substance use disorders and risk of severe maternal morbidity in the United States. Drug and Alcohol Dependence. 2020 Nov 1; 216:108236.
  172. Simpson TL, Hawrilenko M, Goldberg S, Browne K, Lehavot K, Borowitz M. Treatment receipt patterns among individuals with co-occurring posttraumatic stress disorder (PTSD) and substance use disorders. Journal of consulting and clinical psychology. 2020 Nov 1; 88(11):1039-1051.
  173. Gromatsky M, Sullivan SR, Spears AP, Mitchell E, Walsh S, Kimbrel NA, Goodman M. Ecological momentary assessment (EMA) of mental health outcomes in veterans and servicemembers: A scoping review. Psychiatry Research. 2020 Oct 1; 292:113359.
  174. Carter SP, Malte CA, Rojas SM, Hawkins EJ, Reger MA. Examination of potential disparities in suicide risk identification and follow-up care within the Veterans Health Administration. Suicide & Life-Threatening Behavior. 2020 Dec 1; 50(6):1127-1139.
  175. Lin LA, Bohnert ASB, Blow FC, Gordon AJ, Ignacio RV, Kim HM, Ilgen MA. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Addiction (Abingdon, England). 2021 Jan 1; 116(1):96-104.
  176. Coleman BC, Corcoran KL, DeRycke EC, Bastian LA, Brandt CA, Haskell SG, Heapy AA, Lisi AJ. Factors Associated With Posttraumatic Stress Disorder Among Veterans of Recent Wars Receiving Veterans Affairs Chiropractic Care. Journal of Manipulative and Physiological Therapeutics. 2020 Oct 1; 43(8):753-759.
  177. Ahearn EP, Szymanski BR, Chen P, Sajatovic M, Katz IR, McCarthy JF. Increased Risk of Dementia Among Veterans With Bipolar Disorder or Schizophrenia Receiving Care in the VA Health System. Psychiatric services (Washington, D.C.). 2020 Oct 1; 71(10):998-1004.
  178. Adams RS, Garnick DW, Harris AHS, Merrick EL, Hofmann K, Funk W, Williams TV, Larson MJ. Assessing the postdeployment quality of treatment for substance use disorders among Army enlisted soldiers in the Military Health System. Journal of substance abuse treatment. 2020 Jul 1; 114:108026.
  179. McBain SA, Woodward E, Palmer BE, Landes SJ, Wilson MP. Patients accept screening for mental health and substance use disorders while ED clinicians support only if able to refer. The American journal of emergency medicine. 2020 Dec 1; 38(12):2727-2729.
  180. Marsch LA, Campbell A, Campbell C, Chen CH, Ertin E, Ghitza U, Lambert-Harris C, Hassanpour S, Holtyn AF, Hser YI, Jacobs P, Klausner JD, Lemley S, Kotz D, Meier A, McLeman B, McNeely J, Mishra V, Mooney L, Nunes E, Stafylis C, Stanger C, Saunders E, Subramaniam G, Young S. The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network. Journal of substance abuse treatment. 2020 Mar 1; 112S:4-11.
  181. Jones AL, Kertesz SG, Hausmann LRM, Mor MK, Suo Y, Pettey WBP, Schaefer JH, Gundlapalli AV, Gordon AJ. Primary care experiences of veterans with opioid use disorder in the Veterans Health Administration. Journal of substance abuse treatment. 2020 Jun 1; 113:107996.
  182. Munn-Chernoff MA, Johnson EC, Chou YL, Coleman JRI, Thornton LM, Walters RK, Yilmaz Z, Baker JH, Hübel C, Gordon S, Medland SE, Watson HJ, Gaspar HA, Bryois J, Hinney A, Leppä VM, Mattheisen M, Ripke S, Yao S, Giusti-Rodríguez P, Hanscombe KB, Adan RAH, Alfredsson L, Ando T, Andreassen OA, Berrettini WH, Boehm I, Boni C, Boraska Perica V, Buehren K, Burghardt R, Cassina M, Cichon S, Clementi M, Cone RD, Courtet P, Crow S, Crowley JJ, Danner UN, Davis OSP, de Zwaan M, Dedoussis G, Degortes D, DeSocio JE, Dick DM, Dikeos D, Dina C, Dmitrzak-Weglarz M, Docampo E, Duncan LE, Egberts K, Ehrlich S, Escaramís G, Esko T, Estivill X, Farmer A, Favaro A, Fernández-Aranda F, Fichter MM, Fischer K, Föcker M, Foretova L, Forstner AJ, Forzan M, Franklin CS, Gallinger S, Giegling I, Giuranna J, Gonidakis F, Gorwood P, Gratacos Mayora M, Guillaume S, Guo Y, Hakonarson H, Hatzikotoulas K, Hauser J, Hebebrand J, Helder SG, Herms S, Herpertz-Dahlmann B, Herzog W, Huckins LM, Hudson JI, Imgart H, Inoko H, Janout V, Jiménez-Murcia S, Julià A, Kalsi G, Kaminská D, Karhunen L, Karwautz A, Kas MJH, Kennedy JL, Keski-Rahkonen A, Kiezebrink K, Kim YR, Klump KL, Knudsen GPS, La Via MC, Le Hellard S, Levitan RD, Li D, Lilenfeld L, Lin BD, Lissowska J, Luykx J, Magistretti PJ, Maj M, Mannik K, Marsal S, Marshall CR, Mattingsdal M, McDevitt S, McGuffin P, Metspalu A, Meulenbelt I, Micali N, Mitchell K, Monteleone AM, Monteleone P, Nacmias B, Navratilova M, Ntalla I, O'Toole JK, Ophoff RA, Padyukov L, Palotie A, Pantel J, Papezova H, Pinto D, Rabionet R, Raevuori A, Ramoz N, Reichborn-Kjennerud T, Ricca V, Ripatti S, Ritschel F, Roberts M, Rotondo A, Rujescu D, Rybakowski F, Santonastaso P, Scherag A, Scherer SW, Schmidt U, Schork NJ, Schosser A, Seitz J, Slachtova L, Slagboom PE, Slof-Op't Landt MCT, Slopien A, Sorbi S, Swiatkowska B, Szatkiewicz JP, Tachmazidou I, Tenconi E, Tortorella A, Tozzi F, Treasure J, Tsitsika A, Tyszkiewicz-Nwafor M, Tziouvas K, van Elburg AA, van Furth EF, Wagner G, Walton E, Widen E, Zeggini E, Zerwas S, Zipfel S, Bergen AW, Boden JM, Brandt H, Crawford S, Halmi KA, Horwood LJ, Johnson C, Kaplan AS, Kaye WH, Mitchell J, Olsen CM, Pearson JF, Pedersen NL, Strober M, Werge T, Whiteman DC, Woodside DB, Grove J, Henders AK, Larsen JT, Parker R, Petersen LV, Jordan J, Kennedy MA, Birgegård A, Lichtenstein P, Norring C, Landén M, Mortensen PB, Polimanti R, McClintick JN, Adkins AE, Aliev F, Bacanu SA, Batzler A, Bertelsen S, Biernacka JM, Bigdeli TB, Chen LS, Clarke TK, Degenhardt F, Docherty AR, Edwards AC, Foo JC, Fox L, Frank J, Hack LM, Hartmann AM, Hartz SM, Heilmann-Heimbach S, Hodgkinson C, Hoffmann P, Hottenga JJ, Konte B, Lahti J, Lahti-Pulkkinen M, Lai D, Ligthart L, Loukola A, Maher BS, Mbarek H, McIntosh AM, McQueen MB, Meyers JL, Milaneschi Y, Palviainen T, Peterson RE, Ryu E, Saccone NL, Salvatore JE, Sanchez-Roige S, Schwandt M, Sherva R, Streit F, Strohmaier J, Thomas N, Wang JC, Webb BT, Wedow R, Wetherill L, Wills AG, Zhou H, Boardman JD, Chen D, Choi DS, Copeland WE, Culverhouse RC, Dahmen N, Degenhardt L, Domingue BW, Frye MA, Gäebel W, Hayward C, Ising M, Keyes M, Kiefer F, Koller G, Kramer J, Kuperman S, Lucae S, Lynskey MT, Maier W, Mann K, Männistö S, Müller-Myhsok B, Murray AD, Nurnberger JI, Preuss U, Räikkönen K, Reynolds MD, Ridinger M, Scherbaum N, Schuckit MA, Soyka M, Treutlein J, Witt SH, Wodarz N, Zill P, Adkins DE, Boomsma DI, Bierut LJ, Brown SA, Bucholz KK, Costello EJ, de Wit H, Diazgranados N, Eriksson JG, Farrer LA, Foroud TM, Gillespie NA, Goate AM, Goldman D, Grucza RA, Hancock DB, Harris KM, Hesselbrock V, Hewitt JK, Hopfer CJ, Iacono WG, Johnson EO, Karpyak VM, Kendler KS, Kranzler HR, Krauter K, Lind PA, McGue M, MacKillop J, Madden PAF, Maes HH, Magnusson PKE, Nelson EC, Nöthen MM, Palmer AA, Penninx BWJH, Porjesz B, Rice JP, Rietschel M, Riley BP, Rose RJ, Shen PH, Silberg J, Stallings MC, Tarter RE, Vanyukov MM, Vrieze S, Wall TL, Whitfield JB, Zhao H, Neale BM, Wade TD, Heath AC, Montgomery GW, Martin NG, Sullivan PF, Kaprio J, Breen G, Gelernter J, Edenberg HJ, Bulik CM, Agrawal A. Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. Addiction Biology. 2021 Jan 1; 26(1):e12880.
  183. Blonigen DM, Macia KS, Smelson D, Timko C. Criminal recidivism among justice-involved veterans following substance use disorder residential treatment. Addictive Behaviors. 2020 Jul 1; 106:106357.
  184. Finlay A, Binswanger I, Timko C. Introduction to the special issue. Addiction science & clinical practice. 2020 Feb 5; 15(1):5.
  185. Lin LA, Brummett CM, Waljee JF, Englesbe MJ, Gunaseelan V, Bohnert ASB. Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults. Journal of general internal medicine. 2020 Feb 1; 35(2):420-427.
  186. Hayes CJ, Krebs EE, Hudson T, Brown J, Li C, Martin BC. Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study. Addiction (Abingdon, England). 2020 Jun 1; 115(6):1098-1112.
  187. Cox JW, Sherva RM, Lunetta KL, Johnson EC, Martin NG, Degenhardt L, Agrawal A, Nelson EC, Kranzler HR, Gelernter J, Farrer LA. Genome-Wide Association Study of Opioid Cessation. Journal of clinical medicine. 2020 Jan 9; 9(1).
  188. Greer N, Sayer NA, Spoont M, Taylor BC, Ackland PE, MacDonald R, McKenzie L, Rosebush C, Wilt TJ. Prevalence and Severity of Psychiatric Disorders and Suicidal Behavior in Service Members and Veterans With and Without Traumatic Brain Injury: Systematic Review. The Journal of head trauma rehabilitation. 2020 Jan 1; 35(1):1-13.
  189. Pollack HA, Humphreys KN. Reducing violent incidents between police officers and people with psychiatric and/or substance use disorders. The Annals of the American Academy of Political and Social Science. 2020 Jan 1; 687(1):166-184.
  190. Kim B, Bolton RE, Hyde J, Fincke BG, Drainoni ML, Petrakis BA, Simmons MM, McInnes DK. Coordinating across correctional, community, and VA systems: applying the Collaborative Chronic Care Model to post-incarceration healthcare and reentry support for veterans with mental health and substance use disorders. Health & justice. 2019 Dec 12; 7(1):18.
  191. Turvey CL, Lund BC, Jones D, Arndt S. Community Treatment for Opioid Use Disorders in Urban and Rural Veterans. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2020 Mar 1; 36(2):167-176.
  192. Sullivan JL, Davila H, Rosen AK. The Changing Dynamics of Providing Health Care to Older Veterans in the 21st Century: How Do We Best Serve Those Who Have Borne the Battle? GSA 75th Anniversary. Kaskie B, editor. Public Policy & Aging Report: Gerontological Society of America; 2019 Dec 2. 3-5 p. Report No.: 30.
  193. Ecker AH, Lang B, Hogan J, Cucciare MA, Lindsay J. Cannabis use disorder among veterans: Comorbidity and mental health treatment utilization. Journal of substance abuse treatment. 2020 Feb 1; 109:46-49.
  194. Kehle-Forbes SM, Chen S, Polusny MA, Lynch KG, Koffel E, Ingram E, Foa EB, Van Horn DHA, Drapkin ML, Yusko DA, Oslin DW. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug and Alcohol Dependence. 2019 Dec 1; 205:107647.
  195. Lagisetty PA, Lin LA, Ganoczy D, Haffajee RL, Iwashyna TJ, Bohnert ASB. Opioid Prescribing After Opioid-related Inpatient Hospitalizations by Diagnosis: A Cohort Study. Medical care. 2019 Oct 1; 57(10):815-821.
  196. Schmidt EM, Barnes J, Chen C, Trafton J, Frayne S, Harris AHS. Patient and Health Care Factors Associated With Long-term Diabetes Complications Among Adults With and Without Mental Health and Substance Use Disorders. JAMA Network Open. 2019 Sep 4; 2(9):e1912060.
  197. Kathuria H, Seibert RG, Cobb V, Weinstein ZM, Gowarty M, Helm ED, Wiener RS. Patient and Physician Perspectives on Treating Tobacco Dependence in Hospitalized Smokers With Substance Use Disorders: A Mixed Methods Study. Journal of addiction medicine. 2019 Sep 1; 13(5):338-345.
  198. Phillippi SW, Beiter K, Thomas CL, Sugarman OK, Wennerstrom A, Wells KB, Trapido E. Medicaid Utilization Before and After a Natural Disaster in the 2016 Baton Rouge-Area Flood. American journal of public health. 2019 Sep 1; 109(S4):S316-S321.
  199. Creech SK, Pulverman CS, Crawford JN, Holliday R, Monteith LL, Lehavot K, Olson-Madden J, Kelly UA. Clinical Complexity in Women Veterans: A Systematic Review of the Recent Evidence on Mental Health and Physical Health Comorbidities. Behavioral Medicine (Washington, D.C.). 2021 Jan 1; 47(1):69-87.
  200. Dooley-Hash S, Adams M, Walton MA, Blow FC, Cunningham RM. The prevalence and correlates of eating disorders in adult emergency department patients. The International Journal of Eating Disorders. 2019 Nov 1; 52(11):1281-1290.
  201. Browne KC, Hoerster KD, Piegari R, Fortney JC, Nelson KN, Post EP, Fihn SD, Mori AM, Trivedi RB. Clinical Care Quality Among Veterans Health Administration Patients With Mental Illness Following Medical Home Implementation. Psychiatric services (Washington, D.C.). 2019 Sep 1; 70(9):816-823.
  202. Gibson CJ, Li Y, Bertenthal D, Huang AJ, Seal KH. Menopause symptoms and chronic pain in a national sample of midlife women veterans. Menopause (New York, N.Y.). 2019 Jul 1; 26(7):708-713.
  203. Goldberg SB, Livingston WS, Blais RK, Brignone E, Suo Y, Lehavot K, Simpson TL, Fargo J, Gundlapalli AV. A positive screen for military sexual trauma is associated with greater risk for substance use disorders in women veterans. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2019 Aug 1; 33(5):477-483.
  204. Ronzitti S, Loree AM, Potenza MN, Decker SE, Wilson SM, Abel EA, Haskell SG, Brandt CA, Goulet JL. Gender Differences in Suicide and Self-Directed Violence Risk Among Veterans With Post-traumatic Stress and Substance Use Disorders. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2019 Jun 25; 29 Suppl 1:S94-S102.
  205. Wolk CB, Doubeni CA, Klusaritz HA, Bilger A, Paterson E, Oslin DW. Perspectives and Practice in the Identification and Treatment of Opioid Use, Alcohol Use, and Depressive Disorders. Psychiatric services (Washington, D.C.). 2019 Oct 1; 70(10):940-943.
  206. Richards JE, Bobb JF, Lee AK, Lapham GT, Williams EC, Glass JE, Ludman EJ, Achtmeyer C, Caldeiro RM, Oliver M, Bradley KA. Integration of screening, assessment, and treatment for cannabis and other drug use disorders in primary care: An evaluation in three pilot sites. Drug and Alcohol Dependence. 2019 Aug 1; 201:134-141.
  207. Ijadi-Maghsoodi R, Quan M, Horton J, Ryan GW, Kataoka S, Lester P, Milburn NG, Gelberg L. Youth Growing Up in Families Experiencing Parental Substance Use Disorders and Homelessness: A High-Risk Population. Journal of child and adolescent psychopharmacology. 2019 Dec 1; 29(10):773-782.
  208. Kraemer KL, McGinnis KA, Fiellin DA, Skanderson M, Gordon AJ, Robbins J, Zickmund S, Bryant K, Korthuis PT. Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans. Journal of substance abuse treatment. 2019 Aug 1; 103:23-32.
  209. Cordasco KM, Frayne SM, Kansagara D, Zulman DM, Asch SM, Burke RE, Post EP, Fihn SD, Klobucar T, Meyer LJ, Kirsh SR, Atkins D. Coordinating Care Across VA Providers and Settings: Policy and Research Recommendations from VA's State of the Art Conference. Journal of general internal medicine. 2019 May 1; 34(Suppl 1):11-17.
  210. Carlson KF, Gilbert TA, O'Neil ME, Zaugg TL, Manning CA, Kaelin C, Thielman EJ, Reavis KM, Henr y JA. Health Care Utilization and Mental Health Diagnoses Among Veterans With Tinnitus. American Journal of Audiology. 2019 Apr 22; 28(1S):181-190.
  211. Wolitzky-Taylor K, Schiffman J. Predictive Associations Among the Repeated Measurements of Anxiety, Depression, and Craving in a Dual Diagnosis Program. Journal of Dual Diagnosis. 2019 Jul 1; 15(3):140-146.
  212. Ackland PE, Greer N, Sayer NA, Spoont MR, Taylor BC, MacDonald R, McKenzie L, Rosebush C, Wilt TJ. Effectiveness and harms of mental health treatments in service members and veterans with deployment-related mild traumatic brain injury. Journal of affective disorders. 2019 Jun 1; 252:493-501.
  213. Kelly MR, Robbins R, Martin JL. Delivering Cognitive Behavioral Therapy for Insomnia in Military Personnel and Veterans. Sleep medicine clinics. 2019 Jun 1; 14(2):199-208.
  214. Haverfield MC, Ilgen M, Schmidt E, Shelley A, Timko C. Social Support Networks and Symptom Severity Among Patients with Co-occurring Mental Health and Substance Use Disorders. Community mental health journal. 2019 Jul 1; 55(5):768-776.
  215. Greer N, Ackland P, Sayer N, Spoont M, Taylor B, MacDonald R, McKenzie L, Rosebush C, Wilt TJ. Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders: A Systematic Review. 2019 Mar 1.
  216. Ecker A, Stanley MA, Smith TL, Teng E, Fletcher TL, Van Kirk N, Amspoker A, Walder A, McIngvale E, Lindsay JA. Co-occurrence of obsessive compulsive disorder and substance use disorders among U.S. military veterans: Prevalence and mental health utilization. Journal of Cognitive Psychotherapy. 2019 Feb 26; 33:23-32.
  217. Kathuria H, Seibert RG, Cobb V, Herbst N, Weinstein ZM, Gowarty M, Jhunjhunwala R, Helm ED, Wiener RS. Perceived barriers to quitting cigarettes among hospitalized smokers with substance use disorders: A mixed methods study. Addictive Behaviors. 2019 Aug 1; 95:41-48.
  218. McKee MM, Meade MA, Zazove P, Stewart HJ, Jannausch ML, Ilgen MA. The Relationship Between Hearing Loss and Substance Use Disorders Among Adults in the U.S. American journal of preventive medicine. 2019 Apr 1; 56(4):586-590.
  219. Montgomery AE, Szymkowiak D, Cusack MC, Austin EL, Vazzano JK, Kertesz SG, Gabrielian S. Veterans' assignment to single-site versus scattered-site permanent supportive housing. The American Journal of Orthopsychiatry. 2019 Jan 17.
  220. Kang B, Xu H, McConnell ES. Neurocognitive and psychiatric comorbidities of posttraumatic stress disorder among older veterans: A systematic review. International journal of geriatric psychiatry. 2019 Apr 1; 34(4):522-538.
  221. Chermack ST, Bonar EE, Goldstick JE, Winters J, Blow FC, Friday S, Ilgen MA, Rauch SAM, Perron BE, Ngo QM, Walton MA. A randomized controlled trial for aggression and substance use involvement among Veterans: Impact of combining Motivational Interviewing, Cognitive Behavioral Treatment and telephone-based Continuing Care. Journal of substance abuse treatment. 2019 Mar 1; 98:78-88.
  222. Maust DT, Lin LA, Blow FC. Benzodiazepine Use and Misuse Among Adults in the United States. Psychiatric services (Washington, D.C.). 2019 Feb 1; 70(2):97-106.
  223. Seal KH, Borsari B, Tighe J, Cohen BE, Delucchi K, Morasco BJ, Li Y, Sachs E, Abadjian L, Watson EC, Manuel JK, Vella L, Trafton J, Midboe A. Optimizing pain treatment interventions (OPTI): A pilot randomized controlled trial of collaborative care to improve chronic pain management and opioid safety-Rationale, methods, and lessons learned. Contemporary clinical trials. 2019 Feb 1; 77:76-85.
  224. Snow SC, Fonarow GC, Ladapo JA, Washington DL, Hoggatt KJ, Ziaeian B. National Rate of Tobacco and Substance Use Disorders Among Hospitalized Heart Failure Patients. The American journal of medicine. 2019 Apr 1; 132(4):478-488.e4.
  225. Chan B, Edwards ST, Devoe M, Gil R, Mitchell M, Englander H, Nicolaidis C, Kansagara D, Saha S, Korthuis PT. The SUMMIT ambulatory-ICU primary care model for medically and socially complex patients in an urban federally qualified health center: study design and rationale. Addiction science & clinical practice. 2018 Dec 14; 13(1):27.
  226. Hagedorn H, Kenny M, Gordon AJ, Ackland PE, Noorbaloochi S, Yu W, Harris AHS. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities. Addiction science & clinical practice. 2018 Dec 13; 13(1):25.
  227. Thakral M, Walker RL, Saunders K, Shortreed SM, Dublin S, Parchman M, Hansen RN, Ludman E, Sherman KJ, Von Korff M. Impact of Opioid Dose Reduction and Risk Mitigation Initiatives on Chronic Opioid Therapy Patients at Higher Risk for Opioid-Related Adverse Outcomes. Pain medicine (Malden, Mass.). 2018 Dec 1; 19(12):2450-2458.
  228. Boden MT, Hoggatt KJ. Substance Use Disorders Among Veterans in a Nationally Representative Sample: Prevalence and Associated Functioning and Treatment Utilization. Journal of studies on alcohol and drugs. 2018 Nov 1; 79(6):853-861.
  229. Chinman M, McCarthy S, Bachrach RL, Mitchell-Miland C, Schutt RK, Ellison M. Investigating the Degree of Reliable Change Among Persons Assigned to Receive Mental Health Peer Specialist Services. Psychiatric services (Washington, D.C.). 2018 Dec 1; 69(12):1238-1244.
  230. Mooney LJ, Zhu Y, Yoo C, Valdez J, Moino K, Liao JY, Hser YI. Reduction in Cannabis Use and Functional Status in Physical Health, Mental Health, and Cognition. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. 2018 Dec 1; 13(4):479-487.
  231. Barry DT, Marshall BDL, Becker WC, Gordon AJ, Crystal S, Kerns RD, Gaither JR, Gordon KS, Justice AC, Fiellin DA, Edelman EJ. Duration of opioid prescriptions predicts incident nonmedical use of prescription opioids among U.S. veterans receiving medical care. Drug and Alcohol Dependence. 2018 Oct 1; 191:348-354.
  232. Owens MD, Chen JA, Simpson TL, Timko C, Williams EC. Barriers to addiction treatment among formerly incarcerated adults with substance use disorders. Addiction science & clinical practice. 2018 Aug 21; 13(1):19.
  233. Hawkins EJ, Danner AN, Malte CA, Painter JM, Lott AMK, Baer JS. Feasibility of a care management approach for complex substance use disorders and high acute services utilization. Journal of substance abuse treatment. 2018 Sep 1; 92:100-108.
  234. Thomas CP, Ritter GA, Harris AHS, Garnick DW, Freedman KI, Herbert B. Applying American Society of Addiction Medicine Performance Measures in Commercial Health Insurance and Services Data. Journal of addiction medicine. 2018 Jul 1; 12(4):287-294.
  235. Wyse JJ, Morasco BJ, Dobscha SK, Demidenko MI, Meath THA, Lovejoy TI. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified. Journal of opioid management. 2018 Jul 1; 14(4):295-303.
  236. Berg JM, Malte CA, Reger MA, Hawkins EJ. Medical Records Flag for Suicide Risk: Predictors and Subsequent Use of Care Among Veterans With Substance Use Disorders. Psychiatric services (Washington, D.C.). 2018 Sep 1; 69(9):993-1000.
  237. Smelson DA, Chinman M, Hannah G, Byrne T, McCarthy S. An evidence-based co-occurring disorder intervention in VA homeless programs: outcomes from a hybrid III trial. BMC health services research. 2018 May 5; 18(1):332.
  238. Gulliver SB, Zimering R, Knight J, Morissette S, Kamholz B, Meyer E, Keane T, Pennington M, Denman T, Carpenter T, Kimbrel N. Tobacco and alcohol use among firefighters during their first 3 years of service. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2018 May 1; 32(3):255-263.
  239. Quinn PD, Hur K, Chang Z, Scott EL, Krebs EE, Bair MJ, Rickert ME, Gibbons RD, Kroenke K, D'Onofri o BM. Association of Mental Health Conditions and Treatments With Long-term Opioid Analgesic Receipt Among Adolescents. JAMA pediatrics. 2018 May 1; 172(5):423-430.
  240. Stimmel MA, Rosenthal J, Blue-Howells J, Clark S, Harris AHS, Rubinsky AD, Bowe T, Finlay AK. The impact of substance use disorders on treatment engagement among justice-involved veterans with posttraumatic stress disorder. Psychological Services. 2019 Nov 1; 16(4):564-571.
  241. Wong JJ, Cucciare MA, Booth BM, Timko C. Predicting Substance Use Patterns Among Rural Adults: The Roles of Mothers, Fathers, and Parenthood. Family process. 2019 Jun 1; 58(2):431-445.
  242. Tsai J, Finlay A, Flatley B, Kasprow WJ, Clark S. A National Study of Veterans Treatment Court Participants: Who Benefits and Who Recidivates. Administration and policy in mental health. 2018 Mar 1; 45(2):236-244.
  243. Argoff CE, Alford DP, Fudin J, Adler JA, Bair MJ, Dart RC, Gandolfi R, McCarberg BH, Stanos SP, Gudin JA, Polomano RC, Webster LR. Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations. Pain medicine (Malden, Mass.). 2018 Jan 1; 19(1):97-117.
  244. Finlay AK, Harris AHS, Rosenthal J, Blue-Howells J, Clark S, Flatley B, Timko C. Justice Involvement and Treatment Use Among Rural Veterans. Rural mental health. 2018 Jan 1; 42(1):46-59.
  245. Mosher H, Herzig SJ, Danovitch I, Boutsicaris C, Hassamal S, Wittnebel K, Dashti A, Nuckols T. The Evaluation of Medical Inpatients Who Are Admitted on Long-term Opioid Therapy for Chronic Pain. Journal of hospital medicine. 2018 Apr 1; 13(4):249-255.
  246. Owens MD, Kirouac M, Hagler K, Rowell LN, Williams EC. "Being able to speak": What individuals in jail perceived as helpful about participating in alcohol-related brief interventions. Substance Abuse. 2017 Dec 5; 39(3):342-347.
  247. Rubinsky AD, Ellerbe LS, Gupta S, Phelps TE, Bowe T, Burden JL, Harris AHS. Outpatient continuing care after residential substance use disorder treatment in the US Veterans Health Administration: Facilitators and challenges. Substance Abuse. 2017 Dec 5; 39(3):322-330.
  248. Timko C, Ilgen M, Haverfield M, Shelley A, Breland JY. Polysubstance use by psychiatry inpatients with co-occurring mental health and substance use disorders. Drug and Alcohol Dependence. 2017 Nov 1; 180:319-322.
  249. Wang L, Min JE, Krebs E, Evans E, Huang D, Liu L, Hser YI, Nosyk B. Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users. The International Journal On Drug Policy. 2017 Nov 1; 49:32-40.
  250. Sahlem GL, Baker NL, George MS, Malcolm RJ, McRae-Clark AL. Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users. The American journal of drug and alcohol abuse. 2017 Aug 14; 1-9.
  251. Rogal SS, McCarthy R, Reid A, Rodriguez KL, Calgaro L, Patel K, Daley M, Jonassaint NL, Zickmund SL. Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence. Digestive diseases and sciences. 2017 Aug 1; 62(8):1933-1943.
  252. Harrison AJ, Timko C, Blonigen DM. Interpersonal styles, peer relationships, and outcomes in residential substance use treatment. Journal of substance abuse treatment. 2017 Oct 1; 81:17-24.
  253. Noska AJ, Belperio PS, Loomis TP, O'Toole TP, Backu s LI. Prevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Among Homeless and Nonhomeless United States Veterans. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017 Jul 15; 65(2):252-258.
  254. Martindale SL, Farrell-Carnahan LV, Ulmer CS, Kimbrel NA, McDonald SD, Rowland JA, VA Mid-Atlantic MIRECC Registry Workgroup. Sleep quality in returning veterans: The influence of mild traumatic brain injury. Rehabilitation Psychology. 2017 Nov 1; 62(4):563-570.
  255. Hepner KA, Paddock SM, Watkins KE, Ounpraseuth ST, Schrader AM, Hudson TJ. Association Between Quality Measures and Perceptions of Care Among Patients With Substance Use Disorders. Psychiatric services (Washington, D.C.). 2017 Nov 1; 68(11):1150-1156.
  256. Watkins KE, Hudson TJ, Hayes C. Association between Quality Measures and Mortality in Individuals with Co-Occurring Mental Health and Substance Use Disorders. Counselor Magazine. 2017 Jul 1;(Jul-Aug):1.
  257. Ilgen MA, Goldman E. Cognitive behavior therapy for suicide in Veterans with substance use disorders. Suicide Prevention [Cyberseminar]. 2017 Jun 12.
  258. Weintraub D, Claassen DO. Impulse Control and Related Disorders in Parkinson's Disease. International Review of Neurobiology. 2017 Jun 1; 133:679-717.
  259. Hagedorn HJ, Noorbaloochi S, Bangerter A, Stitzer ML, Kivlahan D. Health care cost trajectories in the year prior to and following intake into Veterans Health Administration outpatient substance use disorders treatment. Journal of substance abuse treatment. 2017 Aug 1; 79:46-52.
  260. Meshberg-Cohen S, Kachadourian L, Black AC, Rosen MI. Relationship between substance use and attitudes towards seeking professional psychological help among veterans filing PTSD claims. Addictive Behaviors. 2017 Nov 1; 74:9-12.
  261. Griffith G, Kumaraswami T, Chrysanthopoulou SA, Mattocks KM, Clark RE. Prescription contraception use and adherence by women with substance use disorders. Addiction (Abingdon, England). 2017 Sep 1; 112(9):1638-1646.
  262. Painter JM, Brignone E, Gilmore AK, Lehavot K, Fargo J, Suo Y, Simpson T, Carter ME, Blais RK, Gundlapalli AV. Gender differences in service utilization among Operations Enduring Freedom, Iraqi Freedom, and New Dawn Veterans Affairs patients with severe mental illness and substance use disorders. Psychological Services. 2018 Feb 1; 15(1):11-20.
  263. Lopez AM, Weintraub D, Claassen DO. Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy. Seminars in Neurology. 2017 May 16; 37(2):186-192.
  264. Hawkins EJ, Lott AMK, Malte CA, Frank AN, Hamilton B, Sayre GG, Painter JM, Baer JS. Patients' perspectives on care management services for complex substance use disorders. Journal of addictive diseases. 2017 Jul 1; 36(3):193-206.
  265. Brignone E, Fargo JD, Blais RK, Carter ME, Samore MH, Gundlapalli AV. Non-routine Discharge From Military Service: Mental Illness, Substance Use Disorders, and Suicidality. American journal of preventive medicine. 2017 May 1; 52(5):557-565.
  266. Davis JA, Tsui I, Gelberg L, Gabrielian S, Lee ML, Chang ET. Risk factors for diabetic retinopathy among homeless veterans. Psychological Services. 2017 May 1; 14(2):221-228.
  267. Evans EA, Grella CE, Washington DL, Upchurch DM. Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders. Drug and Alcohol Dependence. 2017 May 1; 174:128-136.
  268. Jones AL, Hausmann LRM, Haas GL, Mor MK, Cashy JP, Schaefer JH, Gordon AJ. A national evaluation of homeless and nonhomeless veterans' experiences with primary care. Psychological Services. 2017 May 1; 14(2):174-183.
  269. Paddock SM, Hepner KA, Hudson T, Ounpraseuth S, Schrader AM, Sullivan G, Watkins KE. Association Between Process-Based Quality Indicators and Mortality for Patients With Substance Use Disorders. Journal of studies on alcohol and drugs. 2017 May 1; 78(4):588-596.
  270. Simmons MM, Gabrielian S, Byrne T, McCullough MB, Smith JL, Taylor TJ, O'Toole TP, Kane V, Yakovchenko V, McInnes DK, Smelso n DA. A Hybrid III stepped wedge cluster randomized trial testing an implementation strategy to facilitate the use of an evidence-based practice in VA Homeless Primary Care Treatment Programs. Implementation science : IS. 2017 Apr 4; 12(1):46.
  271. Gordon AJ, Harding JD. From education to practice: Addressing opioid misuse through health care provider training: A special issue of Substance Abuse journal. Substance Abuse. 2017 Apr 1; 38(2):119-121.
  272. Levy S, Seale JP, Osborne VA, Kraemer KL, Alford DP, Baxter J, Finnell DS, Kunins H, Walley AY, Lewis DC, MacLane-Baeder D, Gordon AJ. The Surgeon General's Facing Addiction report: An historic document for health care. Substance Abuse. 2017 Apr 1; 38(2):122.
  273. Morasco BJ, Yarborough BJ, Smith NX, Dobscha SK, Deyo RA, Perrin NA, Green CA. Higher Prescription Opioid Dose is Associated With Worse Patient-Reported Pain Outcomes and More Health Care Utilization. The journal of pain : official journal of the American Pain Society. 2017 Apr 1; 18(4):437-445.
  274. Simpson TL, Lehavot K, Petrakis IL. No Wrong Doors: Findings from a Critical Review of Behavioral Randomized Clinical Trials for Individuals with Co-Occurring Alcohol/Drug Problems and Posttraumatic Stress Disorder. Alcoholism, clinical and experimental research. 2017 Apr 1; 41(4):681-702.
  275. McCullough M, Smelson DA. Methodological Issues and Data Decisions in the Implementation of a Substance Use Disorders Intervention in VA's Homeless Programs. [Cyberseminar]. HSR&D. 2017 Mar 21.
  276. Higgins DM, Fenton BT, Driscoll MA, Heapy AA, Kerns RD, Bair MJ, Carroll C, Brennan PL, Burgess DJ, Piette JD, Haskell SG, Brandt CA, Goulet JL. Gender Differences in Demographic and Clinical Correlates among Veterans with Musculoskeletal Disorders. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2017 Jul 1; 27(4):463-470.
  277. Bohnert KM, Ilgen MA, Louzon S, McCarthy JF, Katz IR. Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration. Addiction (Abingdon, England). 2017 Jul 1; 112(7):1193-1201.
  278. Pedersen ER, Huang W, Cohen AN, Young AS. Alcohol use and service utilization among veterans in treatment for schizophrenia. Psychological Services. 2018 Feb 1; 15(1):21-30.
  279. Evans EA, Grella CE, Upchurch DM. Gender differences in the effects of childhood adversity on alcohol, drug, and polysubstance-related disorders. Social psychiatry and psychiatric epidemiology. 2017 Jul 1; 52(7):901-912.
  280. Finlay AK, Stimmel M, Blue-Howells J, Rosenthal J, McGuire J, Binswanger I, Smelson D, Harris AH, Frayne SM, Bowe T, Timko C. Use of Veterans Health Administration Mental Health and Substance Use Disorder Treatment After Exiting Prison: The Health Care for Reentry Veterans Program. Administration and policy in mental health. 2017 Mar 1; 44(2):177-187.
  281. Hawkins EJ, Malte CA, Hagedorn HJ, Berger D, Frank A, Lott A, Achtmeyer CE, Mariano AJ, Saxon AJ. Survey of Primary Care and Mental Health Prescribers' Perspectives on Reducing Opioid and Benzodiazepine Co-Prescribing Among Veterans. Pain medicine (Malden, Mass.). 2017 Mar 1; 18(3):454-467.
  282. Jaconis M, Santa Ana EJ, Killeen TK, Badour CL, Back SE. Concurrent treatment of PTSD and alcohol use disorder via telehealth in a female Iraq veteran. The American journal on addictions. 2017 Mar 1; 26(2):112-114.
  283. Lagisetty PA, Maust D, Heisler M, Bohnert A. Physical and Mental Health Comorbidities Associated With Primary Care Visits For Substance Use Disorders. Journal of addiction medicine. 2017 Mar 1; 11(2):161-162.
  284. Lovejoy TI, Morasco BJ, Demidenko MI, Meath TH, Frank JW, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Pain. 2017 Mar 1; 158(3):526-534.
  285. Nahum-Shani I, Ertefaie A, Lu XL, Lynch KG, McKay JR, Oslin DW, Almirall D. A SMART data analysis method for constructing adaptive treatment strategies for substance use disorders. Addiction (Abingdon, England). 2017 May 1; 112(5):901-909.
  286. Barnett PG, Chow A, Flores NE, Sherman SE, Duffy SA. Changes in Veteran Tobacco Use Identified in Electronic Medical Records. American journal of preventive medicine. 2017 Jul 1; 53(1):e9-e18.
  287. Oliva EM, Bowe T, Tavakoli S, Martins S, Lewis ET, Paik M, Wiechers I, Henderson P, Harvey M, Avoundjian T, Medhanie A, Trafton JA. Development and applications of the Veterans Health Administration's Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide. Psychological Services. 2017 Feb 1; 14(1):34-49.
  288. Quinn PD, Hur K, Chang Z, Krebs EE, Bair MJ, Scott EL, Rickert ME, Gibbons RD, Kroenke K, D'Onofri o BM. Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims. Pain. 2017 Jan 1; 158(1):140-148.
  289. Davis AK, Bonar EE, Ilgen MA, Walton MA, Perron BE, Chermack ST. Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment. Addictive Behaviors. 2016 Dec 1; 63:132-6.
  290. Jones AL, Mor MK, Cashy JP, Gordon AJ, Haas GL, Schaefer JH, Hausmann LR. Racial/Ethnic Differences in Primary Care Experiences in Patient-Centered Medical Homes among Veterans with Mental Health and Substance Use Disorders. Journal of general internal medicine. 2016 Dec 1; 31(12):1435-1443.
  291. Gaither JR, Goulet JL, Becker WC, Crystal S, Edelman EJ, Gordon K, Kerns RD, Rimland D, Skanderson M, Justice AC, Fiellin DA. The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality. Journal of addiction medicine. 2016 Nov 1; 10(6):418-428.
  292. Vujanovic AA, Bonn-Miller MO, Petry NM. Co-occurring posttraumatic stress and substance use: Emerging research on correlates, mechanisms, and treatments-Introduction to the special issue. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2016 Nov 1; 30(7):713-719.
  293. Blonigen DM, Bui L, Britt JY, Thomas KM, Timko C. Internalizing and externalizing personality subtypes predict differences in functioning and outcomes among veterans in residential substance use disorder treatment. Psychological assessment. 2016 Oct 1; 28(10):1186-1197.
  294. Gabrielian S, Yuan AH, Andersen RM, Gelberg L. Diagnoses Treated in Ambulatory Care Among Homeless-Experienced Veterans: Does Supported Housing Matter? Journal of primary care & community health. 2016 Oct 1; 7(4):281-7.
  295. Santa Ana EJ, LaRowe SD, Armeson K, Lamb KE, Hartwell K. Impact of group motivational interviewing on enhancing treatment engagement for homeless Veterans with nicotine dependence and other substance use disorders: A pilot investigation. The American journal on addictions. 2016 Oct 1; 25(7):533-41.
  296. Watkins KE, Paddock SM, Hudson TJ, Ounpraseuth S, Schrader AM, Hepner KA, Sullivan G. Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders. Journal of substance abuse treatment. 2016 Oct 1; 69:1-8.
  297. Gilmore AK, Brignone E, Painter JM, Lehavot K, Fargo J, Suo Y, Simpson T, Carter ME, Blais RK, Gundlapalli AV. Military Sexual Trauma and Co-occurring Posttraumatic Stress Disorder, Depressive Disorders, and Substance Use Disorders among Returning Afghanistan and Iraq Veterans. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2016 Sep 1; 26(5):546-54.
  298. Seal KH, Maguen S, Bertenthal D, Batki SL, Striebel J, Stein MB, Madden E, Neylan TC. Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder. The Journal of clinical psychiatry. 2016 Sep 1; 77(9):1182-1188.
  299. Gabrielian S, Young AS, Greenberg JM, Bromley E. Social support and housing transitions among homeless adults with serious mental illness and substance use disorders. Psychiatric Rehabilitation Journal. 2018 Sep 1; 41(3):208-215.
  300. Lovejoy TI, Demidenko MI. A pilot study of group Acceptance and Commitment Therapy for chronic pain in patients with comorbid substance use disorders. Poster session presented at: American Psychological Association Annual Convention; 2016 Aug 4; Denver, CO.
  301. Barry CL, Epstein AJ, Fiellin DA, Fraenkel L, Busch SH. Estimating demand for primary care-based treatment for substance and alcohol use disorders. Addiction (Abingdon, England). 2016 Aug 1; 111(8):1376-84.
  302. Ilgen MA, Bohnert AS, Chermack S, Conran C, Jannausch M, Trafton J, Blow FC. A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction (Abingdon, England). 2016 Aug 1; 111(8):1385-93.
  303. Chereji E, Kern S, Fuller B, Morasco BJ, Phelps A, Hauser P. Co-occurring Depression, Chronic Pain and Substance Use Disorders in People with Hepatitis C. Open medicine journal. 2016 Jul 29; 3(Suppl 1: M5):79-103.
  304. Kehle-Forbes SM, Drapkin ML, Foa EB, Koffel E, Lynch KG, Polusny MA, Van Horn DH, Yusko DA, Charlesworth M, Blasco M, Oslin DW. Study design, interventions, and baseline characteristics for the Substance use and TRauma Intervention for VEterans (STRIVE) trial. Contemporary clinical trials. 2016 Sep 1; 50:45-53.
  305. Chermack ST, Bonar EE, Ilgen MA, Walton MA, Cunningham RM, Booth BM, Blow FC. Developing an Integrated Violence Prevention for Men and Women in Treatment for Substance Use Disorders. Journal of interpersonal violence. 2017 Feb 1; 32(4):581-603.
  306. Raynor P, Pope C. The Role of Self-Care for Parents in Recovery From Substance Use Disorders: An Integrative Review of Parental Self-Care. Journal of addictions nursing. 2016 Jul 1; 27(3):180-9.
  307. Jones AL, Mor MK, Cashy JP, Gordon AJ, Haas GL, Schaefer JS, Hausmann LR. Racial/Ethnic Differences in Patient-Centered Medical Home Experiences Among Veterans with Mental Health and Substance Use Disorders. Poster session presented at: AcademyHealth Annual Research Meeting; 2016 Jun 27; Boston, MA.
  308. Gabrielian SE, Yuan A, Anderson R, Gelberg L. Diagnoses Treated in Ambulatory Care Among Homeless-Experienced Veterans: Does Supported Housing Matter? Paper presented at: AcademyHealth Annual Research Meeting; 2016 Jun 26; Boston, MA.
  309. Moberg CA, Humphreys K. Exclusion criteria in treatment research on alcohol, tobacco and illicit drug use disorders: A review and critical analysis. Drug and Alcohol Review. 2017 May 1; 36(3):378-388.
  310. Stimmel M, McGuire J, Rosenthal J, Rubinsky A, Blue-Howells J, Finlay AK. Justice-involved veterans with posttraumatic stress disorder: Understanding the impact of co-occurring substance use disorders on treatment engagement. Paper presented at: International Association of Forensic Mental Health Services Annual Conference; 2016 Jun 21; New York, NY.
  311. Santa Ana EJ, LaRowe K, Lamb K, Hartwell K. Impact of group motivational interviewing on enhancing treatment engagement for homeless Veterans with nicotine dependence and other substance use disorders: A pilot investigation. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2016 Jun 11; Palm Springs, CA.
  312. Banducci AN, Bujarski SJ, Bonn-Miller MO, Patel A, Connolly KM. The impact of intolerance of emotional distress and uncertainty on veterans with co-occurring PTSD and substance use disorders. Journal of anxiety disorders. 2016 Jun 1; 41:73-81.
  313. Hagedorn HJ, Brown R, Dawes M, Dieperink E, Myrick DH, Oliva EM, Wagner TH, Wisdom JP, Harris AH. Enhancing access to alcohol use disorder pharmacotherapy and treatment in primary care settings: ADaPT-PC. Implementation science : IS. 2016 May 10; 11(1):64.
  314. Lovejoy TI, Morasco BJ, Demidenko MI, Meath TH, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Poster session presented at: American Pain Society Annual Meeting; 2016 May 2; Austin, TX.
  315. Lembke A, Humphreys K. A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation research. Tobacco Control. 2016 May 1; 25(3):261-2.
  316. McDonell MG, Graves MC, West II, Ries RK, Donovan DM, Bumgardner K, Krupski A, Dunn C, Maynard C, Atkins DC, Roy-Byrne P. Utility of Point-of-care Urine Drug Tests in the Treatment of Primary Care Patients With Drug Use Disorders. Journal of addiction medicine. 2016 May 1; 10(3):196-201.
  317. Lovejoy TI, Morasco BJ, Demidenko MI, Meath TH, Frank JW, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. [Abstract]. Pain. 2016 Apr 1; 17(4):s87.
  318. Stringfellow EJ, Kim TW, Gordon AJ, Pollio DE, Grucza RA, Austin EL, Johnson NK, Kertesz SG. Substance use among persons with homeless experience in primary care. Substance Abuse. 2016 Oct 1; 37(4):534-541, DOI: 10.1080/08897077.2016.1145616.
  319. Denneson LM, Cromer RD, Jacobson LE, Teo AR, Dobscha SK. Female Veterans Who Died by Suicide: Qualitative Analysis of Medical Records. Military Behavioral Health. 2016 Feb 17; 4(3):276-284.
  320. Vederhus JK, Clausen T, Humphreys K. Assessing understandings of substance use disorders among Norwegian treatment professionals, patients and the general public. BMC health services research. 2016 Feb 13; 16:52.
  321. Glynn LH, Kendra MS, Timko C, Finlay AK, Blodgett JC, Maisel NC, Midboe AM, McGuire JF, Blonigen DM. Facilitating treatment access and engagement for justice-involved Veterans with substance use disorders. Criminal justice policy review. 2016 Feb 4; 27(2):doi: 10.1177/0887403414560884.
  322. Byrne T, Montgomery AE, Fargo JD. Unsheltered Homelessness Among Veterans: Correlates and Profiles. Community mental health journal. 2016 Feb 1; 52(2):148-57.
  323. Ducharme LJ, Chandler RK, Harris AH. Implementing Effective Substance Abuse Treatments in General Medical Settings: Mapping the Research Terrain. Journal of substance abuse treatment. 2016 Jan 1; 60:110-8.
  324. Gabrielian S, Burns AV, Nanda N, Hellemann G, Kane V, Young AS. Factors Associated With Premature Exits From Supported Housing. Psychiatric services (Washington, D.C.). 2016 Jan 1; 67(1):86-93.
  325. Lan CW, Fiellin DA, Barry DT, Bryant KJ, Gordon AJ, Edelman EJ, Gaither JR, Maisto SA, Marshall BD. The epidemiology of substance use disorders in US Veterans: A systematic review and analysis of assessment methods. The American journal on addictions. 2016 Jan 1; 25(1):7-24.
  326. Outcalt J, Dimaggio G, Popolo R, Buck K, Chaudoin-Patzoldt KA, Kukla M, Olesek KL, Lysaker PH. Metacognition moderates the relationship of disturbances in attachment with severity of borderline personality disorder among persons in treatment of substance use disorders. Comprehensive psychiatry. 2016 Jan 1; 64:22-8.
  327. Evans E, Padwa H, Li L, Lin V, Hser YI. Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment. Journal of substance abuse treatment. 2015 Dec 1; 59:10-9.
  328. Reid MW, Cohen S, Wang H, Kaung A, Patel A, Tashjian V, Williams DL, Martinez B, Spiegel BM. Preventing patient absenteeism: validation of a predictive overbooking model. The American journal of managed care. 2015 Dec 1; 21(12):902-10.
  329. Tsai J, Kasprow WJ, Culhane D, Rosenheck RA. Homeless Veterans Eligible for Medicaid Under the Affordable Care Act. Psychiatric services (Washington, D.C.). 2015 Dec 1; 66(12):1353-6.
  330. Im JJ, Shachter RD, Finney JW, Trafton JA. Toward cost-effective staffing mixes for Veterans Affairs substance use disorder treatment programs. BMC health services research. 2015 Nov 23; 15(1):515.
  331. Curran GM, Woo SM, Hepner KA, Lai WP, Kramer TL, Drummond KL, Weingardt K. Training Substance Use Disorder Counselors in Cognitive Behavioral Therapy for Depression: Development and Initial Exploration of an Online Training Program. Journal of substance abuse treatment. 2015 Nov 1; 58:33-42.
  332. Heslin KC, Gable A, Dobalian A. Special Services for Women in Substance Use Disorders Treatment: How Does the Department of Veterans Affairs Compare with Other Providers? Women's health issues : official publication of the Jacobs Institute of Women's Health. 2015 Nov 1; 25(6):666-72.
  333. Humphreys K, Blodgett JC, Roberts LW. The exclusion of people with psychiatric disorders from medical research. Journal of psychiatric research. 2015 Nov 1; 70:28-32.
  334. Hawkins EJ. Feasibility And Acceptability Of A Collaborative Care Management Approach For Patients With Complex And Chronic Substance Use Disorders. Poster session presented at: Society for Research in Psychopathology Meeting; 2015 Oct 18; New Orleans, LA.
  335. Blonigen DM, Finney JW, Wilbourne P, Moos RH. Psychosocial treatments for substance use disorders. In: Nathan PE, Gorman JM, editors. A guide to treatments that work. 4 ed. New York, NY: Oxford University Press; 2015. 731-761 p.
  336. Gabrielian SE, Bromley E, Greenburg J, Young AS. The Social Context of Housing Transitions among Homeless Veterans with Serious Mental Illness and Substance Use Disorders. Paper presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 8; Philadelphia, PA.
  337. Cucciare MA, Cheung RC, Rongey C. Treating substance use disorders in patients with hepatitis C. [Editorial]. Addiction. 2015 Jul 1; 110(7):1057-9.
  338. Schultz NR, Blonigen D, Finlay A, Timko C. Criminal typology of veterans entering substance abuse treatment. Journal of substance abuse treatment. 2015 Jul 1; 54:56-62.
  339. Finlay AK, Harris A, Blue-Howells J, Rosenthal J, McGuire J, Binswanger I. Receipt of pharmacotherapy for opioid use disorder: Comparing Veterans in Veterans Justice Programs with other Veterans. Poster session presented at: AcademyHealth Annual Research Meeting; 2015 Jun 14; Minneapolis, MN.
  340. Hagedorn HJ, Sox-Harris AH, Wisdom J, Myrick D, Dawes M, Brown R, Oliva E. Implementation of Alcohol Dependence Pharmacotherapy and Treatment in Primary Care (ADAPT-PC). Poster session presented at: AcademyHealth Annual Research Meeting; 2015 Jun 14; Minneapolis, MN.
  341. Harris AH, Ellerbe L, Phelps TE, Finney JW, Bowe T, Gupta S, Asch SM, Humphreys K, Trafton J. Examining the Specification Validity of the HEDIS Quality Measures for Substance Use Disorders. Journal of substance abuse treatment. 2015 Jun 1; 53:16-21.
  342. Smelson DA, Chinman M, McCarthy S, Hannah G, Sawh L, Glickman M. A cluster randomized Hybrid Type III trial testing an implementation support strategy to facilitate the use of an evidence-based practice in VA homeless programs. Implementation science : IS. 2015 May 28; 10(1):79.
  343. Ilgen MA. Intervening to reduce suicide risk in Veterans with substance use disorders. Paper presented at: Military Operational Medicine Research Program In Progress Review Meeting; 2015 May 13; Fort Detrick, MD.
  344. Barnett PG, Hamlett-Berry K, Sung HY, Max W. Health care expenditures attributable to smoking in military veterans. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2015 May 1; 17(5):586-91.
  345. Wasmuth S. Occupation-based intervention for substance use disorders: A systematic review. Poster session presented at: American Occupational Therapy Association Annual Conference; 2015 Apr 16; Nashville, TN.
  346. Finlay AK, Binswanger IA, Smelson D, Sawh L, McGuire J, Rosenthal J, Blue-Howells J, Timko C, Blodgett JC, Harris AH, Asch SM, Frayne S. Sex differences in mental health and substance use disorders and treatment entry among justice-involved Veterans in the Veterans Health Administration. Medical care. 2015 Apr 1; 53(4 Suppl 1):S105-11.
  347. Gabrielian S, Bromley E, Hellemann GS, Kern RS, Goldenson NI, Danley ME, Young AS. Factors affecting exits from homelessness among persons with serious mental illness and substance use disorders. The Journal of clinical psychiatry. 2015 Apr 1; 76(4):e469-76.
  348. Shorey RC, Martino S, Lamb KE, LaRowe SD, Santa Ana EJ. Change talk and relatedness in group motivational interviewing: a pilot study. Journal of substance abuse treatment. 2015 Apr 1; 51:75-81.
  349. Humphreys KN. Circles of Recovery: Mutual Help Organizations for Substance Use Disorders. Presented at: University of Chicago School for Social Service Administration Center for Health Administration Studies Michael M. Davis Seminar Series; 2015 Mar 31; Chicago, IL.
  350. Gifford E, Tavakoli S, Wisdom J, Hamlett-Berry K. Implementation of smoking cessation treatment in VHA substance use disorder residential treatment programs. Psychiatric services (Washington, D.C.). 2015 Mar 1; 66(3):295-302.
  351. Blodgett JC, Avoundjian T, Finlay AK, Rosenthal J, Asch SM, Maisel NC, Midboe AM. Prevalence of mental health disorders among justice-involved veterans. Epidemiologic Reviews. 2015 Jan 19; 37:163-76.
  352. Tsai J, Rosenheck RA. Risk factors for homelessness among US veterans. Epidemiologic Reviews. 2015 Jan 16; 37:177-95.
  353. Humphreys K. Addiction Treatment Professionals Are Not the Gatekeepers of Recovery. Substance use & misuse. 2015 Jan 1; 50(8-9):1024-7.
  354. Hagedorn HJ, Sox-Harris AH, Wisdom J, Myrick D, Dawes M, Brown R, Oliva E. Improving Access to Alcohol Use Disorder Pharmacotherapy and Treatment in Primary Care Settings. Presented at: National Institutes of Health / AcademyHealth Conference on the Science of Dissemination and Implementation; 2014 Dec 9; Bethesda, MD.
  355. Santa Ana EJ, LaRowe S, Lamb K, Tompkins M, Hartwell K. Impact of Group Motivational Interviewing on Enhancing Treatment Engagement for Homeless Veterans with Nicotine Dependence and other Substance Use Disorders: A Pilot Investigation. Paper presented at: American Academy of Addiction Psychiatry Annual Meeting; 2014 Dec 4; Aventura, FL.
  356. Czyz EK, Bohnert AS, King CA, Price AM, Kleinberg F, Ilgen MA. Self-efficacy to avoid suicidal action: factor structure and convergent validity among adults in substance use disorder treatment. Suicide & Life-Threatening Behavior. 2014 Dec 1; 44(6):698-709.
  357. Humphreys K, Frank RG. The Affordable Care Act will revolutionize care for substance use disorders in the United States. Addiction (Abingdon, England). 2014 Dec 1; 109(12):1957-8.
  358. Vanderlip ER, Sullivan MD, Edlund MJ, Martin BC, Fortney J, Austen M, Williams JS, Hudson T. National study of discontinuation of long-term opioid therapy among veterans. Pain. 2014 Dec 1; 155(12):2673-9.
  359. Finlay AK, McGuire J, Rosenthal J, Blue-Howells J, Binswanger I, Smelson D, Sawh L, Timko C, Blodgett JC, Bowe T, Harris A, Clark SC, Asch S, Frayne S. Gender differences in mental health and substance use disorders among justice-involved Veterans after prison incarceration. Poster session presented at: American Society of Criminology Annual Meeting; 2014 Nov 20; San Francisco, CA.
  360. Edlund MJ, Austen MA, Sullivan MD, Martin BC, Williams JS, Fortney JC, Hudson TJ. Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011. Pain. 2014 Nov 1; 155(11):2337-43.
  361. Gaither JR, Goulet JL, Becker WC, Crystal S, Edelman EJ, Gordon K, Kerns RD, Rimland D, Skanderson M, Weisberg DF, Justice AC, Fiellin DA. Guideline-concordant management of opioid therapy among human immunodeficiency virus (HIV)-infected and uninfected veterans. The journal of pain : official journal of the American Pain Society. 2014 Nov 1; 15(11):1130-40.
  362. Frayne SM, Holmes TH, Berg E, Goldstein MK, Berlowitz DR, Miller DR, Pogach LM, Laungani KJ, Lee TT, Moos R. Mental illness and intensification of diabetes medications: an observational cohort study. BMC health services research. 2014 Oct 22; 14:458.
  363. Stimmel MA, Harris AHS, Bowe T, Finlay AK. Co-occurring post-traumatic stress disorder and substance use disorders among Veterans exiting prison. Poster session presented at: Addiction Health Services Research Conference; 2014 Oct 16; Boston, MA.
  364. Cucciare MA, Coleman EA, Saitz R, Timko C. Enhancing transitions from addiction treatment to primary care. Journal of addictive diseases. 2014 Oct 9; 33(4):340-53.
  365. Park TW, Friedmann PD. Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders. Rhode Island medical journal. 2014 Oct 1; 97(10):20-4.
  366. Bradley SM, Stanislawski MA, Bekelman DB, Monteith LL, Cohen BE, Schilling JH, Hunt SC, Milek D, Maddox TM, Ho PM, Shore S, Varosy PD, Matthieu MM, Rumsfeld JS. Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. American heart journal. 2014 Sep 1; 168(3):381-390.e6.
  367. Dedert E, Williams JW, Stein R, McNeil JM, McDuffie J, Ross I, Feiermuth C, Hemminger A, Kosinski A, Nagi A. e-Interventions for Alcohol Misuse. Washington (DC): Department of Veterans Affairs; 2014 Sep 1. 101 p.
  368. Grossbard JR, Malte CA, Saxon AJ, Hawkins EJ. Clinical monitoring and high-risk conditions among patients with SUD newly prescribed opioids and benzodiazepines. Drug and Alcohol Dependence. 2014 Sep 1; 142:24-32.
  369. McLellan AT, Starrels JL, Tai B, Gordon AJ, Brown R, Ghitza U, Gourevitch M, Stein J, Oros M, Horton T, Lindblad R, McNeely J. Can substance use disorders be managed using the chronic care model? Review and recommendation from a NIDA Consensus Group. Public Health Reviews. 2014 Sep 1; 35(2):1-14.
  370. Williams EC, Rubinsky AD, Chavez LJ, Lapham GT, Rittmueller SE, Achtmeyer CE, Bradley KA. An early evaluation of implementation of brief intervention for unhealthy alcohol use in the US Veterans Health Administration. Addiction (Abingdon, England). 2014 Sep 1; 109(9):1472-81.
  371. Pilkey D, Steinberg H, Martino S. Evidence-based Treatments for Substance Use Disorders. In: Kaye AD, Vadivelu N, Urman RD, editors. Substance Abuse: Inpatient and Outpatient Management for Every Clinician. New York, NY: Springer; 2014. Chapter 17. 209-28 p.
  372. McGlynn G. FORUM-3: Care Coordination. 2014 Aug 25; 6(3).
  373. Maisto S, Jenkins J, Gordon AJ. SUD QUERI funding opportunity (DVA Substance Use Disorders QUERI Primary Care Work Group Monthly e-Bulletin). [Newsletter]. 2014 Aug 19; 3(6).
  374. Gordon AJ, Maisto S, Jenkins J. Department of Veterans Affairs Substance Use Disorders QUERI Primary Care Work Group Monthly e-Bulletin (Featured SUD QUERI Research Project: Effectiveness of Brief Alcohol Counseling Implementation). [Newsletter]. 2014 Aug 4; 3(5).
  375. Blonigen DM, Bui L, Harris AH, Hepner KA, Kivlahan DR. Perceptions of behavioral health care among veterans with substance use disorders: results from a national evaluation of mental health services in the Veterans Health Administration. Journal of substance abuse treatment. 2014 Aug 1; 47(2):122-9.
  376. Hundt NE, Barrera TL, Mott JM, Mignogna J, Yu HJ, Sansgiry S, Stanley MA, Cully JA. Predisposing, enabling, and need factors as predictors of low and high psychotherapy utilization in veterans. Psychological Services. 2014 Aug 1; 11(3):281-9.
  377. Timko C, Cucciare MA, Ilgen M. Facilitating care transitions among patients with substance use disorders. VA HSR&D FORUM: Translating research into quality health care for Veterans. 2014 Aug 1; 6.
  378. Tsai J, Rosenheck RA. Homeless and nonhomeless VA service users likely eligible for Medicaid expansion. Journal of rehabilitation research and development. 2014 Aug 1; 51(5):675-84.
  379. Tsai J, Rosenheck RA, Kane V. Homeless female U.S. veterans in a national supported housing program: comparison of individual characteristics and outcomes with male veterans. Psychological Services. 2014 Aug 1; 11(3):309-16.
  380. Hagedorn HJ, Stetler CB, Bangerter A, Noorbaloochi S, Stitzer ML, Kivlahan D. An implementation-focused process evaluation of an incentive intervention effectiveness trial in substance use disorders clinics at two Veterans Health Administration medical centers. Addiction science & clinical practice. 2014 Jul 9; 9(1):12.
  381. Callegari LS, Zhao X, Nelson KM, Lehavot K, Bradley KA, Borrero S. Associations of mental illness and substance use disorders with prescription contraception use among women veterans. Contraception. 2014 Jul 1; 90(1):97-103.
  382. Gordon AJ, Maisto S, Jenkins J. Brief alcohol intervention training for integrated providers in primary care (DVA Substance Use Disorders QUERI Primary Care Work Group Monthly e-Bulletin). [Newsletter]. 2014 Jun 30; 3(4).
  383. Gros DF, Back SE, Killeen T, Teer A, Beylotte F, McCauley JL, Hellmuth J, Brady KT. Gender differences in trauma and substance use characteristics among Veterans with PTSD and substance use disorders. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 14; San Juan, Puerto Rico.
  384. Finlay AK, Smelson D, Timko C, McGuire J, Rosenthal J, Sawh L, Bowe T, Harris AH. Justice-involved Veterans: Mental health and substance use disorder conditions and utilization of care. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 9; San Diego, CA.
  385. Cheney AM, Dunn A, Booth BM, Frith L, Curran GM. Incorporating women Veterans' preferences into treatments for co-occurring mental health and substance use disorders. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 8; San Diego, CA.
  386. Finlay AK, McGuire J, Rosenthal J, Blue-Howells J, Binswanger I, Blodgett JC, Bowe T, Harris AH, Asch SM, Frayne SM. Women justice-involved Veterans: Mental health and substance use disorders. Poster session presented at: AcademyHealth Gender and Health Interest Group Annual Meeting; 2014 Jun 7; San Diego, CA.
  387. Sellinger JJ. All roads lead to Rome: Furthering physician involvement in the care of patients with substance use disorders. [Newsletter]. 2014 May 14; 4(2).
  388. Higgins DM, Kerns RD, Brandt CA, Haskell SG, Bathulapalli H, Gilliam W, Goulet JL. Persistent pain and comorbidity among Operation Enduring Freedom/Operation Iraqi Freedom/operation New Dawn veterans. Pain medicine (Malden, Mass.). 2014 May 1; 15(5):782-90.
  389. Bonn-Miller MO. Cannabis Use: Treatment and Policy Implications. VAPAHCS Substance Use Disorders Clinical Licensure Training Series, Palo Alto, CA. 2014 Apr 30.
  390. Gabrielian S, Bromley E, Hellemann G, Goldenson N, Danley M, Young AS. Improving housing outcomes for homeless persons with serious mental illness and co-occurring substance use disorders. Poster session presented at: National Institute of Mental Health Mental Health Services Research Annual Conference; 2014 Apr 4; Bethesda, MD.
  391. Chinman M, George P, Dougherty RH, Daniels AS, Ghose SS, Swift A, Delphin-Rittmon ME. Peer support services for individuals with serious mental illnesses: assessing the evidence. Psychiatric services (Washington, D.C.). 2014 Apr 1; 65(4):429-41.
  392. Vandrey R, Babson KA, Herrmann ES, Bonn-Miller MO. Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders. International review of psychiatry (Abingdon, England). 2014 Apr 1; 26(2):237-47.
  393. Gordon AJ, Maisto S, Jenkins J. Department of Veterans Affairs Substance Use Disorders QUERI Primary Care Work Group Monthly e-Bulletin. [Newsletter]. 2014 Mar 28; 3(2).
  394. Sullivan M, Vanderlip E, Edlund MJ, Hudson TJ. Characteristics and treatment interests among individuals with substance use disorders and a history of past six-month violence: Findings from an emergency department study. Paper presented at: American Academy of Pain Medicine Annual Meeting; 2014 Mar 6; Phoenix, AZ.
  395. Najavits L, Lung J, Froias A, Paull N, Bailey G. A study of multiple behavioral addictions in a substance abuse sample. Substance use & misuse. 2014 Mar 1; 49(4):479-84.
  396. O'Neil ME, Carlson KF, Storzbach D, Brenner LA, Freeman M, Quiñones AR, Motu'apuak a M, Kansagara D. Factors associated with mild traumatic brain injury in veterans and military personnel: a systematic review. Journal of the International Neuropsychological Society : JINS. 2014 Mar 1; 20(3):249-61.
  397. Prisciandaro JJ, McRae-Clark AL, Myrick H, Henderson S, Brady KT. Brain activation to cocaine cues and motivation/treatment status. Addiction Biology. 2014 Mar 1; 19(2):240-9.
  398. Bonn-Miller MO. Cannabis: Characteristics, Prevalence, Correlates, Medical Use, and Treatment. Invited talk to 2nd year Substance Use Disorders Class (Dr. Nancy Haug, Professor), Palo Alto University, Palo Alto, CA. 2014 Feb 28.
  399. O'Neil ME, Carlson KF, Storzbach D, Brenner LA, Freeman M, Quiñones AR, Motu'apuak a M, Kansagara D. Factors Associated with Mild Traumatic Brain Injury in Veterans and Military Personnel: A Systematic Review. Journal of the International Neuropsychological Society : JINS. 2014 Feb 5; 1-13.
  400. Blodgett JC, Maisel NC, Fuh IL, Wilbourne PL, Finney JW. How effective is continuing care for substance use disorders? A meta-analytic review. Journal of substance abuse treatment. 2014 Feb 1; 46(2):87-97.
  401. Garfield LD, Scherrer JF, Hauptman PJ, Freedland KE, Chrusciel T, Balasubramanian S, Carney RM, Newcomer JW, Owen R, Bucholz KK, Lustman PJ. Association of anxiety disorders and depression with incident heart failure. Psychosomatic medicine. 2014 Feb 1; 76(2):128-36.
  402. Tsai J, Kasprow WJ, Rosenheck RA. Alcohol and drug use disorders among homeless veterans: prevalence and association with supported housing outcomes. Addictive Behaviors. 2014 Feb 1; 39(2):455-60.
  403. Williams EC, Rubinsky AD, Lapham GT, Chavez LJ, Rittmueller SE, Hawkins EJ, Grossbard JR, Kivlahan DR, Bradley KA. Prevalence of clinically recognized alcohol and other substance use disorders among VA outpatients with unhealthy alcohol use identified by routine alcohol screening. Drug and Alcohol Dependence. 2014 Feb 1; 135:95-103.
  404. Bauer MS, Lee A, Li M, Bajor L, Rasmusson A, Kazis LE. Off-label use of second generation antipsychotics for post-traumatic stress disorder in the Department of Veterans Affairs: time trends and sociodemographic, comorbidity, and regional correlates. Pharmacoepidemiology and drug safety. 2014 Jan 1; 23(1):77-86.
  405. Broyles LM, Binswanger IA, Jenkins JA, Finnell DS, Faseru B, Cavaiola A, Pugatch M, Gordon AJ. Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response. [Editorial]. Substance Abuse. 2014 Jan 1; 35(3):217-21.
  406. Chermack ST, Murray R, Kraus S, Walton MA, Cunningham RM, Barry KL, Booth BM, Blow FC. Characteristics and treatment interests among individuals with substance use disorders and a history of past six-month violence: findings from an emergency department study. Addictive Behaviors. 2014 Jan 1; 39(1):265-72.
  407. Hassett AL, Aquino JK, Ilgen MA. The risk of suicide mortality in chronic pain patients. Current Pain and Headache Reports. 2014 Jan 1; 18(8):436.
  408. Morasco BJ, O'Neil ME, Duckart JP, Ganzi ni L. Comparison of health service use among veterans with methamphetamine versus alcohol use disorders. Journal of addiction medicine. 2014 Jan 1; 8(1):47-52.
  409. Babson KA, Del Re AC, Bonn-Miller MO, Woodward SH. The comorbidity of sleep apnea and mood, anxiety, and substance use disorders among obese military veterans within the Veterans Health Administration. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2013 Dec 15; 9(12):1253-8.
  410. Weimer MB, Macey TA, Nicolaidis C, Dobscha SK, Duckart JP, Morasco BJ. Sex differences in the medical care of VA patients with chronic non-cancer pain. Pain medicine (Malden, Mass.). 2013 Dec 1; 14(12):1839-47.
  411. Jain S, Hernandez J, Rosen CS, Lindley S. The peer support program: An innovative clinical program for Veterans with PTSD and substance use disorders living in rural California. Presented at: International Society for Traumatic Stress Studies Annual Symposium; 2013 Nov 7; Philadelphia, PA.
  412. Gordon AJ, Bertholet N, McNeely J, Starrels JL, Tetrault JM, Walley AY. 2013 Update in addiction medicine for the generalist. Addiction science & clinical practice. 2013 Nov 4; 8(1):18.
  413. El-Gabalawy R, Tsai J, Harpaz-Rotem I, Hoff R, Sareen J, Pietrzak RH. Predominant typologies of psychopathology in the United States: a latent class analysis. Journal of psychiatric research. 2013 Nov 1; 47(11):1649-57.
  414. Harris AH, Finney J, Asch S, Ellerbe L, Phelps T, Bowe T, Gupta S, Humphreys K, Trafton J. Examining the Specification Validity of the HEDIS Quality Measures for Substance Use Disorders. Presented at: Addiction Health Services Research Conference; 2013 Oct 24; Portland, OR.
  415. Hepner KA, Paddock SM, Watkins KE, Blonigen DM, Pincus H. Perceptions of care among Veterans with substance use disorders. Presented at: Addiction Health Services Research Conference; 2013 Oct 24; Portland, OR.
  416. Gordon AJ, Harding JD. Length of treatment evidence (DVA Substance Use Disorders QUERI Primary Care Work Group Monthly e-Bulletin). [Newsletter]. 2013 Oct 6; 8(3).
  417. Bohnert AS, McCarthy JF, Ignacio RV, Ilgen MA, Eisenberg A, Blow FC. Misclassification of suicide deaths: examining the psychiatric history of overdose decedents. Injury Prevention : Journal of The International Society For Child and Adolescent Injury Prevention. 2013 Oct 1; 19(5):326-30.
  418. Dedert E, McDuffie JR, Swinkels C, Shaw R, Fulton J, Allen KD, Datta S, Williams JW. Computerized Cognitive Behavioral Therapy for Adults with Depressive or Anxiety Disorders. Washington (DC): Department of Veterans Affairs (US); 2013 Oct 1. 108 p.
  419. Dedert E, McDuffie JR, Swinkles C, Shaw R, Fulton J, Allen KD, Datta S, Williams JW. Computerized Cognitive Behavioral Therapy for Adults With Depressive or Anxiety Disorders. VA-ESP Project #09-010. Washington, DC: HSR&D; 2013 Oct 1. 10 p.
  420. Flückiger C, Del Re AC, Horvath AO, Symonds D, Ackert M, Wampol d BE. Substance use disorders and racial/ethnic minorities matter: a meta-analytic examination of the relation between alliance and outcome. Journal of counseling psychology. 2013 Oct 1; 60(4):610-6.
  421. Finney JW, Moos RH, Timko C. The course of treated and untreated substance use disorders: Remission and resolution, relapse and mortality. In: Addictions: A Comprehensive Guidebook. 2nd ed. New York, NY: Oxford University Press; 2013. 108-131 p.
  422. Oliva EM, Bowe T, Harris AH, Trafton JA. Datapoints: false starts in psychotherapy for substance use disorders and PTSD in the VHA. Psychiatric services (Washington, D.C.). 2013 Aug 1; 64(8):722.
  423. Frakt AB, Trafton J, Wallace A, Neuman M, Pizer S. Directed funding to address under-provision of treatment for substance use disorders: a quantitative study. Implementation science : IS. 2013 Jul 18; 8:79.
  424. Hagedorn HJ, Noorbaloochi S, Simon AB, Bangerter A, Stitzer ML, Stetler CB, Kivlahan D. Rewarding early abstinence in Veterans Health Administration addiction clinics. Journal of substance abuse treatment. 2013 Jul 1; 45(1):109-17.
  425. Pavao J, Turchik JA, Hyun JK, Karpenko J, Saweikis M, McCutcheon S, Kane V, Kimerling R. Military sexual trauma among homeless veterans. Journal of general internal medicine. 2013 Jul 1; 28 Suppl 2:S536-41.
  426. Thomas CP, Garnick DW, Horgan CM, Miller K, Harris AH, Rosen MM. Establishing the feasibility of measuring performance in use of addiction pharmacotherapy. Journal of substance abuse treatment. 2013 Jul 1; 45(1):11-8.
  427. Rosen AK, Chen Qi, O'Brien W, Borzecki AM, Frakt AB, Shwartz M, Baue r MS. Assessing the Impact of Serious Mental Illness (SMI) and Substance Use Disorders (SUD) on Risk of Readmission for Patients with Acute Myocardial Infarction, Heart Failure, and Pneumonia in the Veterans Health Administration (VA). Presented at: AcademyHealth Annual Research Meeting; 2013 Jun 25; Baltimore, MD.
  428. Burnett-Zeigler I, Ilgen MA, Bohnert K, Miller E, Islam K, Zivin K. The impact of psychiatric disorders on employment: results from a national survey (NESARC). Community mental health journal. 2013 Jun 1; 49(3):303-10.
  429. Gifford EV, Tavakoli S, Wang R, Hagedorn HJ, Hamlett-Berry KW. Tobacco dependence diagnosis and treatment in Veterans Health Administration residential substance use disorder treatment programs. Addiction (Abingdon, England). 2013 Jun 1; 108(6):1127-35.
  430. Gallagher RM. Co-occurring chronic pain and substance use disorders: clinical challenges and promising treatment approaches. Paper presented at: American Pain Society Annual Meeting; 2013 May 9; New Orleans, LA.
  431. Chakravorty S, Grandner MA, Kranzler HR, Mavandadi S, Kling MA, Perlis ML, Oslin DW. Insomnia in alcohol dependence: predictors of symptoms in a sample of veterans referred from primary care. The American journal on addictions. 2013 May 1; 22(3):266-70.
  432. O'Connor K, Kline A, Sawh L, Fisher W, Rodrigues S, Kane V, Kuhn J, Ellison ML, Smelso n DA. Unemployment and Co-occurring Disorders Among Homeless Veterans. Journal of Dual Diagnosis. 2013 Mar 27; 9(2):134-138.
  433. Mittal D. Maintenance of Certification Symposium: The feedback modules of the performance in practice component of the ABPN MOC program substance use disorders. Paper presented at: American Association for Geriatric Psychiatry Annual Meeting; 2013 Mar 14; Los Angeles, CA.
  434. Lozano BE, LaRowe SD, Smith JP, Tuerk P, Roitzsch J. Brief motivational feedback may enhance treatment entry in veterans with comorbid substance use and psychiatric disorders. The American journal on addictions. 2013 Mar 1; 22(2):132-5.
  435. Meis LA, Griffin JM, Greer N, Jensen AC, Macdonald R, Carlyle M, Rutks I, Wilt TJ. Couple and family involvement in adult mental health treatment: a systematic review. Clinical Psychology Review. 2013 Mar 1; 33(2):275-86.
  436. Hanks D. Emerging Evidence-1: Feb '13-Substance Use Disorders and Mental Health. 2013 Feb 28; 4(1).
  437. Bohnert KM, Ilgen MA, Rosen CS, Desai RA, Austin K, Blow FC. The association between substance use disorders and mortality among a cohort of Veterans with posttraumatic stress disorder: variation by age cohort and mortality type. Drug and Alcohol Dependence. 2013 Feb 1; 128(1-2):98-103.
  438. Dobscha SK, Morasco BJ, Duckart JP, Macey T, Deyo RA. Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. The Clinical Journal of Pain. 2013 Feb 1; 29(2):102-8.
  439. Humensky JL, Jordan N, Stroupe KT, Hynes D. Employment status of veterans receiving substance abuse treatment from the U.S. Department of Veterans Affairs. Psychiatric services (Washington, D.C.). 2013 Feb 1; 64(2):177-80.
  440. Bonar EE, Bohnert AS, Ilgen MA, Sanborn ML, Chermack ST. Physical assault victimization and coping among adults in residential substance use disorder treatment. Violence and victims. 2013 Jan 1; 28(5):849-64.
  441. Babson KA, Blonigen DM, Boden MT, Drescher KD, Bonn-Miller MO. Sleep quality among U.S. military veterans with PTSD: a factor analysis and structural model of symptoms. Journal of traumatic stress. 2012 Dec 1; 25(6):665-74.
  442. Tsai J, Rosenheck RA, McGuire JF. Comparison of outcomes of homeless female and male veterans in transitional housing. Community mental health journal. 2012 Dec 1; 48(6):705-10.
  443. Levy CE. Knowledge Now: Update on Mild TBI. Paper presented at: American Academy of Physical Medicine and Rehabilitation Annual Assembly; 2012 Nov 15; Atlanta, GA.
  444. Gordon AJ. Substance use disorders among homeless in HPACTS: challenges and opportunities. [Cyberseminar]. 2012 Nov 5.
  445. Conners EE, Hagedorn HJ, Butler JN, Felmet K, Hoang T, Wilson P, Klima G, Sudzina E, Anaya HD. Evaluating the implementation of nurse-initiated HIV rapid testing in three Veterans Health Administration substance use disorder clinics. International Journal of STD & AIDS. 2012 Nov 1; 23(11):799-805.
  446. Maguen S, Metzler TJ, Bosch J, Marmar CR, Knight SJ, Neylan TC. Killing in combat may be independently associated with suicidal ideation. Depression and anxiety. 2012 Nov 1; 29(11):918-23.
  447. Hanks D. QUERI eNews-1. [Newsletter]. 2012 Oct 15; 5(1).
  448. Adams CE, Gabriele JM, Baillie LE, Dubbert PM. Tobacco use and substance use disorders as predictors of postoperative weight loss 2 years after bariatric surgery. The journal of behavioral health services & research. 2012 Oct 1; 39(4):462-71.
  449. Burnett-Zeigler I, Zivin K, Islam K, Ilgen MA. Longitudinal predictors of first time depression treatment utilization among adults with depressive disorders. Social psychiatry and psychiatric epidemiology. 2012 Oct 1; 47(10):1617-25.
  450. Tracy S, Tavakoli S, Stolpner S, Trafton JA. Treating Substance Use Disorders within the Veterans Affairs Health Care System. In: Miller TW, editor. The Praeger Handbook of Veterans' Health [4 volumes]: History, Challenges, Issues, and Developments. 3rd ed. New York, NY: Praeger; 2012. Chapter 6. 169-198 p.
  451. Timko C, Valenstein H, Lin PY, Moos RH, Stuart GL, Cronkite RC. Addressing substance abuse and violence in substance use disorder treatment and batterer intervention programs. Substance abuse treatment, prevention, and policy. 2012 Sep 7; 7(1):37.
  452. Cucciare MA, Weingardt KR, Greene CJ, Hoffman J. Current trends in using Internet and mobile technology to support the treatment of substance use disorders. Current drug abuse reviews. 2012 Sep 1; 5(3):172-7.
  453. Hawkins EJ, Malte CA, Baer JS, Kivlahan DR. Prevalence, predictors, and service utilization of patients with recurrent use of Veterans Affairs substance use disorder specialty care. Journal of substance abuse treatment. 2012 Sep 1; 43(2):221-30.
  454. Hawkins EJ, Grossbard J, Benbow J, Nacev V, Kivlahan DR. Evidence-based screening, diagnosis, and treatment of substance use disorders among veterans and military service personnel. Military medicine. 2012 Aug 1; 177(8 Suppl):29-38.
  455. Grossbard JR, Hawkins EJ, Williams EC, Rubinsky AF, Lapham GT, Johnson-Chavez M, Bradley KA. Rates of Alcohol Misuse and Follow-Up Care among OEF/OIF Veterans in VA: Associations with Substance Use Disorders and PTSD. Poster session presented at: VA HSR&D / QUERI National Meeting; 2012 Jul 19; National Harbor, MD.
  456. Kulkarni M, Oliva EM, Timko C, Trafton JA, Kimerling R. Patterns of Specialty Care Utilization by Veterans with PTSD and Substance Use Disorders. Poster session presented at: VA HSR&D / QUERI National Meeting; 2012 Jul 16; National Harbor, MD.
  457. Wagner TH, Harris AH, Moos RH, McKellar JD. Assessing the Efficacy of Telephone Monitoring among Veterans with Substance Use Disorders. Poster session presented at: VA HSR&D / QUERI National Meeting; 2012 Jul 16; National Harbor, MD.
  458. Bonn-Miller MO, Bucossi MM, Trafton JA. The underdiagnosis of cannabis use disorders and other Axis-I disorders among military veterans within VHA. Military medicine. 2012 Jul 1; 177(7):786-8.
  459. Bradley KA, Rubinsky AD, Sun H, Blough DK, Tønnesen H, Hughes G, Beste LA, Bishop MJ, Hawn MT, Maynard C, Harris AS, Hawkins EJ, Bryson CL, Houston TK, Henderson WG, Kivla han DR. Prevalence of alcohol misuse among men and women undergoing major noncardiac surgery in the Veterans Affairs health care system. Surgery. 2012 Jul 1; 152(1):69-81.
  460. Walker R, Hunt YM, Olivier J, Grothe KB, Dubbert PM, Burke RS, Cushman WC. Descriptive characteristics and cluster analysis of male veteran hazardous drinkers in an alcohol moderation intervention. The American journal on addictions. 2012 Jul 1; 21(4):335-42.
  461. Cucciare MA, Ghaus S, Weingardt KR. Symposia: Randomized Controlled Trials of Web-based interventions for alcohol and substance use disorders: Results and Future Directions. Presented at: Research Society on Alcoholism Annual Scientific Meeting; 2012 Jun 26; San Francisco, CA.
  462. Hagedorn HJ, Noorbaloochi S. Impact of an Incentive Program on Treatment Outcomes for Veterans with Alcohol or Stimulant Dependence. Paper presented at: AcademyHealth Annual Research Meeting; 2012 Jun 24; Orlando, FL.
  463. Kulkarni M, Oliva EM, Timko C, Trafton JA, Kimerling R. Examining Patterns of Special Care Utilization by Veterans with PTSD and Substance Use Disorders. Poster session presented at: Research Society on Alcoholism Annual Scientific Meeting; 2012 Jun 24; San Francisco, CA.
  464. Meis L, Griffin JM, Greer NL, Jensen AC, Carlyle M, MacDonald R, Rutks IR, Wilt TJ. Family Involved Psychosocial Treatments for Adult Mental Health Conditions: A Review of the evidence. VA-ESP Project #09-009. 2012 Jun 1.
  465. Zinzow HM, Resnick HS, McCauley JL, Amstadter AB, Ruggiero KJ, Kilpatrick DG. Prevalence and risk of psychiatric disorders as a function of variant rape histories: results from a national survey of women. Social psychiatry and psychiatric epidemiology. 2012 Jun 1; 47(6):893-902.
  466. Humphreys K. Federal policy on criminal offenders who have substance use disorders: how can we maximize public health and public safety? Substance Abuse. 2012 May 17; 33(1):5-8.
  467. Ruglass LM, Miele GM, Hien DA, Campbell AN, Hu MC, Caldeira N, Jiang H, Litt L, Killeen T, Hatch-Maillette M, Najavits L, Brown C, Robinson JA, Brigham GS, Nunes EV. Helping alliance, retention, and treatment outcomes: a secondary analysis from the NIDA Clinical Trials Network Women and Trauma Study. Substance use & misuse. 2012 May 1; 47(6):695-707.
  468. Yoon J, Scott JY, Phibbs CS, Frayne SM. Trends in rates and attributable costs of conditions among female VA patients, 2000 and 2008. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2012 May 1; 22(3):e337-44.
  469. Adams C, Gabriele J, Dubbert PM. Tobacco Use and Substance Use Disorders as Predictors of Postoperative Weight Loss Two Years After Bariatric Surgery. Paper presented at: Society of Behavioral Medicine Annual Meeting and Scientific Sessions; 2012 Apr 11; New Orleans, LA.
  470. Harpaz-Rotem I, Rosenheck RA, Desai R. Residential treatment for homeless female veterans with psychiatric and substance use disorders: effect on 1-year clinical outcomes. Journal of rehabilitation research and development. 2012 Apr 5; 48(8):891-9.
  471. Duffy SA, Kilbourne AM, Austin KL, Dalack GW, Woltmann EM, Waxmonsky J, Noonan D. Risk of smoking and receipt of cessation services among veterans with mental disorders. Psychiatric services (Washington, D.C.). 2012 Apr 1; 63(4):325-32.
  472. Nazarian D, Kimerling R, Frayne SM. Posttraumatic stress disorder, substance use disorders, and medical comorbidity among returning U.S. veterans. Journal of traumatic stress. 2012 Apr 1; 25(2):220-5.
  473. Smelson D, Kalman D, Losonczy MF, Kline A, Sambamoorthi U, Hill LS, Castles-Fonseca K, Ziedonis D. A brief treatment engagement intervention for individuals with co-occurring mental illness and substance use disorders: results of a randomized clinical trial. Community mental health journal. 2012 Apr 1; 48(2):127-32.
  474. Frayne SM, Carney DV. VA Women’s Health Practice-Based Research Network (Teleconference). To the National VA Substance Use Disorders QUERI Specialty Care Workgroup. 2012 Mar 8.
  475. Rodrigues S, Kline A, Sawh L, Smelson DA, O'Connor K, Kane V, Kuhn J, Serper M, Ziedon is D. Childhood experiences and demographic characteristics of homeless veterans with co-occurring mental health and substance use disorders in MISSION. Poster session presented at: American Psychopathological Association Annual Meeting; 2012 Mar 6; New York, NY.
  476. Boden MT, Kimerling R, Jacobs-Lentz J, Bowman D, Weaver C, Carney D, Walser R, Trafton JA. Seeking Safety treatment for male veterans with a substance use disorder and post-traumatic stress disorder symptomatology. Addiction (Abingdon, England). 2012 Mar 1; 107(3):578-86.
  477. Copeland LA, Pugh MJ, Hicks PB, Noel PH. Use of obesity-related care by psychiatric patients. Psychiatric services (Washington, D.C.). 2012 Mar 1; 63(3):230-6.
  478. Ilgen MA, Conner KR, Roeder KM, Blow FC, Austin K, Valenstein M. Patterns of treatment utilization before suicide among male veterans with substance use disorders. American journal of public health. 2012 Mar 1; 102 Suppl 1:S88-92.
  479. Lemke S, Schaefer JA. Addressing substance use disorders in VA nursing homes. Journal of social work practice in the addictions. 2012 Feb 22; 12(1):89-106.
  480. Bohnert AS, Ilgen MA, Ignacio RV, McCarthy JF, Valenstein M, Blow FC. Risk of death from accidental overdose associated with psychiatric and substance use disorders. The American journal of psychiatry. 2012 Jan 1; 169(1):64-70.
  481. Chermack ST, Bohnert AS, Price AM, Austin K, Ilgen MA. Substance use disorders and homicide death in veterans. Journal of studies on alcohol and drugs. 2012 Jan 1; 73(1):10-4.
  482. Santa Ana EJ, Stallings DL, Rounsaville BJ, Martino S. Development of an in-home telehealth program for outpatient veterans with substance use disorders. Psychological Services. 2013 Aug 1; 10(3):304-314.
  483. Humphreys K, McLellan AT. A policy-oriented review of strategies for improving the outcomes of services for substance use disorder patients. Addiction (Abingdon, England). 2011 Dec 1; 106(12):2058-66.
  484. Hagedorn HJ. Evaluating the Implementation of Nurse-Initiated HIV Rapid Testing in VA Substance Use Disorder Clinics. Paper presented at: American Public Health Association Annual Meeting and Exposition; 2011 Nov 2; Washington, DC.
  485. Olfson M, Ascher-Svanum H, Faries DE, Marcus SC. Predicting psychiatric hospital admission among adults with schizophrenia. Psychiatric services (Washington, D.C.). 2011 Oct 1; 62(10):1138-45.
  486. Oliva EM, Maisel NC, Gordon AJ, Harris AH. Barriers to use of pharmacotherapy for addiction disorders and how to overcome them. Current psychiatry reports. 2011 Oct 1; 13(5):374-81.
  487. Austin J, McKellar JD, Moos R. The influence of co-occurring axis I disorders on treatment utilization and outcome in homeless patients with substance use disorders. Addictive Behaviors. 2011 Sep 1; 36(9):941-4.
  488. Morasco BJ, Duckart JP, Dobscha SK. Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder. Journal of general internal medicine. 2011 Sep 1; 26(9):965-71.
  489. Pfeiffer PN, Ganoczy D, Bowersox NW, McCarthy JF, Blow FC, Valenstein M. Depression care following psychiatric hospitalization in the veterans health administration. The American journal of managed care. 2011 Sep 1; 17(9):e358-64.
  490. Price AM, Ilgen MA, Bohnert AS. Prevalence and correlates of nonmedical use of prescription opioids in patients seen in a residential drug and alcohol treatment program. Journal of substance abuse treatment. 2011 Sep 1; 41(2):208-14.
  491. Harris AH. Developing and Validating Metrics of Uniform Handbook Elements Related to Substance Use Disorders (SUD). Presented at: VA Mental Health Annual Conference; 2011 Aug 24; Baltimore, MD.
  492. Blow FC, Walton MA, Barry KL, Murray RL, Cunningham RM, Massey LS, Chermack ST, Booth BM. Alcohol and drug use among patients presenting to an inner-city emergency department: a latent class analysis. Addictive Behaviors. 2011 Aug 1; 36(8):793-800.
  493. Krebs EE, Becker WC, Zerzan J, Bair MJ, McCoy K, Hui S. Comparative mortality among Department of Veterans Affairs patients prescribed methadone or long-acting morphine for chronic pain. Pain. 2011 Aug 1; 152(8):1789-95.
  494. Schaefer JA, Cronkite RC, Hu KU. Differential relationships between continuity of care practices, engagement in continuing care, and abstinence among subgroups of patients with substance use and psychiatric disorders. Journal of studies on alcohol and drugs. 2011 Jul 1; 72(4):611-21.
  495. Seal KH, Cohen G, Waldrop A, Cohen BE, Maguen S, Ren L. Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001-2010: Implications for screening, diagnosis and treatment. Drug and Alcohol Dependence. 2011 Jul 1; 116(1-3):93-101.
  496. Hagedorn HJ. Rewarding Early Abstinence and Treatment Participation: the effect of motivational incentives on substance use disorders treatment outcomes. Paper presented at: AcademyHealth Annual Research Meeting; 2011 Jun 14; Seattle, WA.
  497. Damschroder LJ, Hagedorn HJ. A guiding framework and approach for implementation research in substance use disorders treatment. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2011 Jun 1; 25(2):194-205.
  498. Finney JW, Hagedorn HJ. Introduction to a special section on implementing evidence-based interventions for substance use disorders. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2011 Jun 1; 25(2):191-3.
  499. Manuel JK, Hagedorn HJ, Finney JW. Implementing evidence-based psychosocial treatment in specialty substance use disorder care. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2011 Jun 1; 25(2):225-37.
  500. Pfeiffer PN, Ganoczy D, Zivin K, Valenstein M. Benzodiazepines and adequacy of initial antidepressant treatment for depression. Journal of Clinical Psychopharmacology. 2011 Jun 1; 31(3):360-4.
  501. Smith MW, Lemke S, Schaefer J. Substance use disorders and health care costs among veterans affairs nursing home residents. Medical care. 2011 Jun 1; 49(6):538-44.
  502. Hagedorn HJ. Implementing motivational incentive in VA substance use disorders treatment. Paper presented at: VA VISN 23 Mental Health Research Conference; 2011 May 5; Sioux Falls, SD.
  503. Goebel JR, Compton P, Zubkoff L, Lanto A, Asch SM, Sherbourne CD, Shugarman L, Lorenz KA. Prescription sharing, alcohol use, and street drug use to manage pain among veterans. Journal of pain and symptom management. 2011 May 1; 41(5):848-58.
  504. Ilgen MA, Roeder KM, Webster L, Mowbray OP, Perron BE, Chermack ST, Bohnert AS. Measuring pain medication expectancies in adults treated for substance use disorders. Drug and Alcohol Dependence. 2011 May 1; 115(1-2):51-6.
  505. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011 Apr 6; 305(13):1315-21.
  506. Bohnert AS, Zivin K, Welsh DE, Kilbourne AM. Ratings of patient-provider communication among veterans: serious mental illnesses, substance use disorders, and the moderating role of trust. Health communication. 2011 Apr 1; 26(3):267-74.
  507. Wagner TH, Sinnott P, Siroka AM. Mental health and substance use disorder spending in the Department of Veterans Affairs, fiscal years 2000-2007. Psychiatric services (Washington, D.C.). 2011 Apr 1; 62(4):389-95.
  508. Humphreys KN. Responding to Substance Use Disorders in Military Personnel and their Dependents. Paper presented at: Institute of Medicine: Prevention, Diagnosis, Treatment and Management of Substance Use Disorders in the U.S. Armed Forces Conference; 2011 Mar 30; Washington, DC.
  509. Nazarian D, Kimerling R, Frayne SM. Association between PTSD, substance use disorders, and medical conditions among returning Veterans. Paper presented at: American Psychosomatic Society Annual Scientific Meeting; 2011 Mar 10; San Antonio, TX.
  510. Morasco BJ, Gritzner S, Lewis L, Oldham R, Turk DC, Dobscha SK. Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain. 2011 Mar 1; 152(3):488-97.
  511. Hagedorn HJ, Noorbaloochi S, Rimmele CT, Kivlahan DR. Rewarding Early Abstinence and Treatment Participation (REAP): The Effect of Motivational Incentives on Substance Use Disorders Treatment Outcomes. Paper presented at: VA HSR&D National Meeting; 2011 Feb 17; Baltimore, MD.
  512. McGlynn G, Hecht MI, Hagedorn H. Short Video-10: Mental Health and Substance Use Disorders, by Hildi Hagedorn. 2010 Dec 2; 1(10).
  513. Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain. 2010 Dec 1; 151(3):625-32.
  514. Frueh BC, Paul LA, Yeager D, Grubaugh AL, Magruder KM. Substance use disorders in Veterans Affairs primary care clinics and relations to mental health outcomes. Poster session presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2010 Nov 18; San Francisco, CA.
  515. Humphreys KN, McLellan AT. Brief intervention, treatment, and recovery support services for Americans who have substance use disorders: An overview of policy in the Obama administration. Psychological Services. 2010 Nov 1; 7(4):275-284.
  516. Ilgen MA, Bohnert AS, Ignacio RV, McCarthy JF, Valenstein MM, Kim HM, Blow FC. Psychiatric diagnoses and risk of suicide in veterans. Archives of general psychiatry. 2010 Nov 1; 67(11):1152-8.
  517. Humphreys KN. Managing Substance Use Disorders in Primary Care: Lessons from Developed and Developing Countries. Presented at: World Congress of Social Psychiatry; 2010 Oct 26; Marrakech, Morocco.
  518. Rubinsky AF, Lapham GT, Kivlahan DR, Williams EC, Hawkins EJ, Bradley KA. Prevalence of Previously Recognized Alcohol and Other Substance Use Disorders among VA Patients who Screen Positive for Alcohol Misuse. Presented at: AcademyHealth Annual Fall Seminar; 2010 Sep 27; Boston, MA.
  519. Hanks D. QUERI eNews-2, QUERI Center Updates, Announcements, and Recent Publications. [Newsletter]. 2010 Sep 21; 3(2).
  520. Ilgen MA, Perron B, Czyz EK, McCammon RJ, Trafton J. The timing of onset of pain and substance use disorders. The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 2010 Sep 1; 19(5):409-15.
  521. Kilbourne AM, Keyser D, Pincus HA. Challenges and opportunities in measuring the quality of mental health care. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 2010 Sep 1; 55(9):549-57.
  522. Tiet QQ, Schutte KK. Detection rates of substance use disorders. Paper presented at: American Psychological Association Annual Convention; 2010 Aug 12; San Diego, CA.
  523. Edlund MJ, Harris KM, Koenig HG, Han X, Sullivan G, Mattox R, Tang L. Religiosity and decreased risk of substance use disorders: is the effect mediated by social support or mental health status? Social psychiatry and psychiatric epidemiology. 2010 Aug 1; 45(8):827-36.
  524. Kimerling R, Street AE, Pavao J, Smith MW, Cronkite RC, Holmes TH, Frayne SM. Military-related sexual trauma among Veterans Health Administration patients returning from Afghanistan and Iraq. American journal of public health. 2010 Aug 1; 100(8):1409-12.
  525. Shen C, Findley P, Banerjea R, Sambamoorthi U. Depressive disorders among cohorts of women veterans with diabetes, heart disease, and hypertension. Journal of women's health (2002). 2010 Aug 1; 19(8):1475-86.
  526. Tsai J, Bond GR, Salyers MP, Godfrey JL, Davis KE. Housing preferences and choices among adults with mental illness and substance use disorders: a qualitative study. Community mental health journal. 2010 Aug 1; 46(4):381-8.
  527. Cretzmeyer MT, Mengeling M, Sadler AG, Torner J, Booth B. Alcohol use by Female Veterans Receiving Antidepressant Therapy. Paper presented at: VA HSR&D Field-Based Women's Health Meeting; 2010 Jul 16; Washington, DC.
  528. Weitlauf JC, Waldrop A, Manning E, Jones S, Finney JW. Impact of substance use disorders and PTSD on receipt of cervical cancer screening. Presented at: VA HSR&D Field-Based Women's Health Meeting; 2010 Jul 14; Arlington, VA.
  529. Baldwin ML, Marcus SC, De Simone J. Job loss discrimination and former substance use disorders. Drug and Alcohol Dependence. 2010 Jul 1; 110(1-2):1-7.
  530. Lemke S, Schaefer JA. VA nursing home residents with substance use disorders: Mental health comorbidities, functioning, and problem behaviors. Aging & mental health. 2010 Jul 1; 14(5):593-602.
  531. Nazarian D, Kimerling R, Frayne SM. PTSD, substance use disorders, and medical comorbidity among women and men returning Veterans in primary care: A key role for behavioral medicine. Presented at: VA HSR&D Field-Based Women's Health Meeting; 2010 Jul 1; Arlington, VA.
  532. Vaughn MG, Fu Q, Perron BE, Bohnert AS, Howard MO. Is crack cocaine use associated with greater violence than powdered cocaine use? Results from a national sample. The American journal of drug and alcohol abuse. 2010 Jul 1; 36(4):181-6.
  533. Hagedorn HJ, Noorbaloochi S, Rimmele C, Kivlahan D. Rewarding Early Abstinence and Treatment Participation in Substance Use Disorders Treatment. Poster session presented at: AcademyHealth Annual Research Meeting; 2010 Jun 28; Boston, MA.
  534. Bohnert AS. The impact of psychiatric and substance use disorders on the risk of fatal accidental overdose among Veterans. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2010 Jun 14; Scottsdale, AZ.
  535. Hagedorn HJ, Heideman PW. The relationship between baseline Organizational Readiness to Change Assessment subscale scores and implementation of hepatitis prevention services in substance use disorders treatment clinics: a case study. Implementation science : IS. 2010 Jun 14; 5:46.
  536. Gordon AJ. Integration of care with homeless populations. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2010 Jun 12; Scottsdale, AZ.
  537. Weingardt KR. Using technology to support screening, identification and early intervention for psychiatric and substance use disorders. Paper presented at: VA Psychology Leadership Conference; 2010 May 14; San Antonio, TX.
  538. Cretzmeyer MT, Mengeling M, Booth BM, Torner J, Sadler AG. Women Veterans: Alcohol use by Female Veterans Receiving Antidepressant Therapy. Poster session presented at: VA HSR&D Field-Based Mental Health and Substance Use Disorders Meeting; 2010 Apr 28; Little Rock, AR.
  539. Nazarian D, Kimerling R, Frayne SM. PTSD, Substance Use Disorders, and Medical Comorbidity among OEF/OIF Veterans in Primary Care: Prevalence and Implications for Behavioral Medicine Interventions. Paper presented at: VA HSR&D Field-Based Mental Health and Substance Use Disorders Meeting; 2010 Apr 28; Little Rock, AR.
  540. Kilbourne AM, Fullerton C, Dausey D, Pincus HA, Hermann RC. A framework for measuring quality and promoting accountability across silos: the case of mental disorders and co-occurring conditions. Quality & Safety in Health Care. 2010 Apr 1; 19(2):113-6.
  541. Harris AH. Can We Strengthen the Links Between Process Quality Measures and Outcomes? Performance Measurement for Substance Use Disorders: A Research Agenda. Paper presented at: Substance Abuse and Mental Health Services Administration / National Institute on Drug Abuse Meeting; 2010 Mar 24; Washington, DC.
  542. Humphreys KN. Policies for improving systems of care for substance use disorders. Presented at: International Society for the Study of Drug Policy Annual Conference; 2010 Mar 23; Santa Monica, CA.
  543. Green KM, Doherty EE, Reisinger HS, Chilcoat HD, Ensminger M. Social integration in young adulthood and the subsequent onset of substance use and disorders among a community population of urban African Americans. Addiction. 2010 Mar 1; 105(3):484-93.
  544. Timko C, Sutkowi A, Moos R. Patients with dual diagnoses or substance use disorders only: 12-step group participation and 1-year outcomes. Substance use & misuse. 2010 Mar 1; 45(4):613-27.
  545. Hagedorn HJ, Rettmann NA, Dieperink EW, Durfee J, Aqel B. Antibody response to hepatitis B vaccine in substance use disorder patients. Drug and Alcohol Dependence. 2010 Feb 1; 107(1):39-43.
  546. Ilgen MA, Burnette ML, Conner KR, Czyz E, Murray R, Chermack S. The association between violence and lifetime suicidal thoughts and behaviors in individuals treated for substance use disorders. Addictive Behaviors. 2010 Feb 1; 35(2):111-5.
  547. Hagedorn H, Leighton T, Heim L. Assessment of a hepatitis educational group for veterans with substance use disorders. The American journal of drug and alcohol abuse. 2010 Jan 1; 36(1):57-60.
  548. Henry SR, Hagedorn HJ, Feld JE, Golden JF, Horns HL, Knapp HE, Anaya HD. A formative evaluation of organizational readiness to implement nurse-initiated HIV rapid testing in two veterans health administration substance use disorders clinics. Journal of HIV/AIDS and Social Services. 2010 Jan 1; 9(1):7-26.
  549. Inslicht SS, McCaslin SE, Metzler TJ, Henn-Haase C, Hart SL, Maguen S, Neylan TC, Marmar CR. Family psychiatric history, peritraumatic reactivity, and posttraumatic stress symptoms: a prospective study of police. Journal of psychiatric research. 2010 Jan 1; 44(1):22-31.
  550. McInnes DK, Hyun JK, Trafton JA, Asch SM, Gifford AL. Program characteristics associated with testing for HIV and hepatitis C in veterans substance use disorder clinics. Psychiatric services (Washington, D.C.). 2010 Jan 1; 61(1):90-4.
  551. Brady KT, Tuerk PW, Back SE, Saladin ME, Waldrop AE, Myrick H. Combat PTSD and Substance Use Disorders. Journal of Addictive Medicine. 2009 Dec 15; 3(4):179-188.
  552. Tuerk P, Brady KT, Grubaugh AL. Clinical Case Discussion: Combat PTSD and Substance Use Disorders. Journal of addiction medicine. 2009 Dec 1; 3(4):189-93.
  553. Humphreys KN. Lessons from the VA experience about how the federal Government can improve the treatment of substance use disorders. Presented at: Tory Shadow Cabinet and Backbench Members of Parliament Briefing; Washington, DC. 2009 Nov 22.
  554. Banerjea R, Pogach LM, Smelson DA, Sambamoorthi U. Multi-morbidity in Physical Illness and Co-occurring Mental Illness and Substance Use Disorders: Who are at Risk? Poster session presented at: American Public Health Association Annual Meeting and Exposition; 2009 Nov 7; Philadelphia, PA.
  555. Banerjea R, Findley PA, Smith B, Findley T, Sambamoorthi U. Co-occurring medical and mental illness and substance use disorders among veteran clinic users with spinal cord injury patients with complexities. Spinal Cord. 2009 Nov 1; 47(11):789-95.
  556. Banerjea R, Pogach LM, Smelson D, Sambamoorthi U. Mental illness and substance use disorders among women veterans with diabetes. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2009 Nov 1; 19(6):446-56.
  557. Bossi KE. Publication eBriefs-1, Oct 09, Quality, HIV, PTSD, OEF/OIF. 2009 Oct 15; 2(1).
  558. Dookeran NM, Burgess JF, Bowman CC, Goetz MB, Asch SM, Gifford AL. HIV screening among substance-abusing veterans in care. Journal of substance abuse treatment. 2009 Oct 1; 37(3):286-91.
  559. Lorenz KA, Krebs EE, Bentley TG, Sherbourne CD, Goebel JR, Zubkoff L, Lanto AB, Asch SM. Exploring alternative approaches to routine outpatient pain screening. Pain medicine (Malden, Mass.). 2009 Oct 1; 10(7):1291-9.
  560. McCollister KE, French MT, Pyne JM, Booth B, Rapp R, Carr C. The cost of treating addiction from the client's perspective: results from a multi-modality application of the Client DATCAP. Drug and Alcohol Dependence. 2009 Oct 1; 104(3):241-8.
  561. Banerjea R, Findley P, Findley TW, Sambamoorthi U. Prevalence of Mental Illness and Substance Use Disorders and their Impact on Mortality among Veteran Clinic Users with Spinal Cord Injury. Paper presented at: Spinal Cord Medicine and Rehabilitation Annual Congress; 2009 Sep 24; Dallas, TX.
  562. Cucciare MA, Weingardt KR, Humphreys K. How Internet technology can improve the quality of care for substance use disorders. Current drug abuse reviews. 2009 Sep 1; 2(3):256-62.
  563. Hagedorn HJ, Noorbaloochi S, Rimmele C, Kivalan D. Effectiveness of a Contingency Management Intervention for Veterans with Substance Use Disorders. Presented at: VA MIRECC Annual Best Practices in Mental Health Conference; 2009 Jul 1; Baltimore, MD.
  564. Hagedorn HJ, Noorbaloochi S, Rimmele C, Kivlahan D. Effectiveness of a Contingency Management Intervention for Veterans with Substance Use Disorders. Poster session presented at: AcademyHealth Annual Research Meeting; 2009 Jun 28; Chicago, IL.
  565. Leighton TR, Heim LA, Hagedorn HJ. Assessment of a Hepatitis Education Group Serving Veterans in a Substance Use Disorders Clinic. Poster session presented at: AcademyHealth Annual Research Meeting; 2009 Jun 28; Chicago, IL.
  566. Thomas CP, Seidmann MR, Horgan C, Miller K, Harris AH. Measuring Performance in Use of Pharmacotherapy for Substance Use Disorders in Different Health Systems. Paper presented at: AcademyHealth Annual Research Meeting; 2009 Jun 28; Boston, MA.
  567. Murray RL, Chermack ST, Walton MA, Massey LS, Cunningham R, Barry KL, De Chavez P, Booth BM, Blow FC. Treatment Interests Among Individuals With Substance Use Disorders And A Past-Year History of Violence: Findings From An Emergency Department Study. Paper presented at: Research Society on Alcoholism Annual Scientific Meeting; 2009 Jun 25; San Diego, CA.
  568. Al-Hasnawi SM, Aqrawi R, Sadik S, Humphreys K. Datapoints: Iraqi psychiatrists' perceptions of substance use disorders among patients. Psychiatric services (Washington, D.C.). 2009 Jun 1; 60(6):728.
  569. Bossi KE. HSR&D Pub eBriefs-b, May 09-Performance Measure, Suicide, Access, Cancer. 2009 May 5; 1(2).
  570. Smith MW, Ananth L, Chow A, Lemke S, Schaefer JA. Costs of care for VA nursing home patients with substance use disorders. Paper presented at: VA HSR&D National Meeting; 2009 Feb 24; Baltimore, MD.
  571. Bohnert A, Zivin KZ, Welsh D, Kilbourne AM. Patient-Provider communication among Veterans with Serious Mental Illnesses and Substance Use Disorders. Poster session presented at: VA HSR&D National Meeting; 2009 Feb 13; Baltimore, MD.
  572. Findley P, Findley TW, Banerjea R, Sambamoorthi U. Mental Illness, Substance Use Disorders and Mortality among Veteran Clinic Users with Spinal Cord Injury. Paper presented at: VA HSR&D National Meeting; 2009 Feb 11; Baltimore, MD.
  573. Smith MW, Lemke S, Schaefer JA, Chow A, Ananth L. Nursing home patients with substance use disorders: Implications for cost of care. Presented at: VA HSR&D National Meeting; 2009 Feb 11; Baltimore, MD.
  574. Wojnar M, Ilgen MA, Wojnar J, McCammon RJ, Valenstein M, Brower KJ. Sleep problems and suicidality in the National Comorbidity Survey Replication. Journal of psychiatric research. 2009 Feb 1; 43(5):526-31.
  575. Dickerson DL, O'Malley SS, Canive J, Thuras P, Westermey er J. Nicotine dependence and psychiatric and substance use comorbidities in a sample of American Indian male veterans. Drug and Alcohol Dependence. 2009 Jan 1; 99(1-3):169-75.
  576. Humphreys K, Harris AH, Kivlahan DR. Performance monitoring of substance use disorder interventions in the Veterans Health Administration. The American journal of drug and alcohol abuse. 2009 Jan 1; 35(3):123-7.
  577. Irmiter C, Barry KL, Cohen K, Blow FC. Sixteen-year predictors of substance use disorder diagnoses for patients with mental health disorders. Substance Abuse. 2009 Jan 1; 30(1):40-6.
  578. Kilbourne AM, Biswas K, Pirraglia PA, Sajatovic M, Williford WO, Bauer MS. Is the collaborative chronic care model effective for patients with bipolar disorder and co-occurring conditions? Journal of affective disorders. 2009 Jan 1; 112(1-3):256-61.
  579. McKellar JD, Harris AH, Moos RH. Patients' abstinence status affects the benefits of 12-step self-help group participation on substance use disorder outcomes. Drug and Alcohol Dependence. 2009 Jan 1; 99(1-3):115-22.
  580. Pfeiffer PN, Ganoczy D, Ilgen M, Zivin K, Valenstein M. Comorbid anxiety as a suicide risk factor among depressed veterans. Depression and anxiety. 2009 Jan 1; 26(8):752-7.
  581. Yano EM, Young AS, Cohen AN, Hamilton A, Rubenstein LV. Can Six Blind Men Find Apples & Oranges: Using Multiple Data Sources to Describe Variable Implementation of QI Interventions. Paper presented at: VA QUERI National Meeting; 2008 Dec 8; Phoenix, AZ.
  582. Curran GM, Sullivan G, Williams K, Han X, Allee E, Kotrla KJ. The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: an observational cohort study. BMC emergency medicine. 2008 Dec 3; 8:17.
  583. Groessl EJ, Weingart KR, Kaplan RM, Clark JA, Gifford AL, Ho SB. Living with hepatitis C: qualitative interviews with hepatitis C-infected veterans. Journal of general internal medicine. 2008 Dec 1; 23(12):1959-65.
  584. Hanks D. QUERI Impact Updates. 2008 Dec 1; 1(1).
  585. Lohoff FW, Weller AE, Bloch PJ, Nall AH, Ferraro TN, Kampman KM, Pettinati HM, Oslin DW, Dackis CA, O'Brien CP, Berrettin i WH. Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. Neuropsychopharmacology. 2008 Dec 1; 33(13):3078-84.
  586. Weingardt KR. Technology-based training in Cognitive Behavioral Therapy for Substance Use Disorders: Does a flexible training model improve learner outcomes? Paper presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2008 Nov 15; Orlando, FL.
  587. Humphreys KN. Why cost offset studies do not convince medical centers to expand treatment for substance use disorders. Paper presented at: Society for the Study of Addiction Annual Symposium; 2008 Nov 12; York, United Kingdom.
  588. Hanks D. QUERI Fact Sheets, Nov 08. 2008 Nov 7; 2(1).
  589. Elwy AR, Ranganathan G, Eisen SV. Race-ethnicity and diagnosis as predictors of outpatient service use among treatment initiators. Psychiatric services (Washington, D.C.). 2008 Nov 1; 59(11):1285-91.
  590. Ilgen MA, Zivin K, McCammon RJ, Valenstein M. Pain and suicidal thoughts, plans and attempts in the United States. General hospital psychiatry. 2008 Nov 1; 30(6):521-7.
  591. Korthuis PT, Zephyrin LC, Fleishman JA, Saha S, Josephs JS, McGrath MM, Hellinger J, Gebo KA, HIV Research Network. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care and Stds. 2008 Nov 1; 22(11):859-67.
  592. Tiwari A, Rajan M, Miller D, Pogach L, Olfson M, Sambamoorthi U. Guideline-consistent antidepressant treatment patterns among veterans with diabetes and major depressive disorder. Psychiatric services (Washington, D.C.). 2008 Oct 1; 59(10):1139-47.
  593. Burnette ML, Ilgen M, Frayne SM, Lucas E, Mayo J, Weitlauf JC. Violence perpetration and childhood abuse among men and women in substance abuse treatment. Journal of substance abuse treatment. 2008 Sep 1; 35(2):217-22.
  594. Demarce JM, Lash SJ, Stephens RS, Grambow SC, Burden JL. Promoting continuing care adherence among substance abusers with co-occurring psychiatric disorders following residential treatment. Addictive Behaviors. 2008 Sep 1; 33(9):1104-12.
  595. Ilgen MA, Hu KU, Moos RH, McKellar J. Continuing care after inpatient psychiatric treatment for patients with psychiatric and substance use disorders. Psychiatric services (Washington, D.C.). 2008 Sep 1; 59(9):982-8.
  596. Lohoff FW, Bloch PJ, Weller AE, Nall AH, Doyle GA, Buono RJ, Ferraro TN, Kampman KM, Pettinati HM, Dackis CA, Oslin DW, O'Brien CP, Berrettin i WH. Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence. Neuroscience Letters. 2008 Aug 8; 440(3):280-3.
  597. Chermack ST, Zivin K, Valenstein M, Ilgen M, Austin KL, Wryobeck J, Blow FC. The prevalence and predictors of mental health treatment services in a national sample of depressed veterans. Medical care. 2008 Aug 1; 46(8):813-20.
  598. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Expenditures in mental illness and substance use disorders among veteran clinic users with diabetes. The journal of behavioral health services & research. 2008 Jul 1; 35(3):290-303.
  599. Whitehead AJ, Dobscha SK, Morasco BJ, Ruimy S, Bussell C, Hauser P. Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. Journal of pain and symptom management. 2008 Jul 1; 36(1):39-45.
  600. Murray, Chermack ST, Walton, Winters, Blow, Booth. Psychological aggression, physical aggression and injury in non-partner relationships among men and women in treatment for substance use disorders. Poster session presented at: Research Society on Alcoholism Annual Scientific Meeting; 2008 Jun 29; Washington, DC.
  601. Banerjea R, Sambamoorthi U, Pogach LM, Weaver F, Findley TW. Mental Illness and Substance Use Disorders Among Veteran Clinic Users with Spinal Cord Injury. Poster session presented at: AcademyHealth Annual Research Meeting; 2008 Jun 15; Washington, DC.
  602. Hagedorn H, Rettmann N, Dieperink E, Durfee J, Aqel B. Seroconversion Rates after Hepatitis B Vaccination in Patients Seeking Treatment for Substance Use Disorders. Poster session presented at: AcademyHealth Annual Research Meeting; 2008 Jun 8; Washington, DC.
  603. Smith MW, Lemke S, Schaefer J, Chow A, Ananth L. Nursing home patients with substance use disorders: Implications for cost of care. Poster session presented at: AcademyHealth Annual Research Meeting; 2008 Jun 8; Washington, DC.
  604. Scherrer JF, Xian H, Lyons MJ, Goldberg J, Eisen SA, True WR, Tsuang M, Bucholz KK, Koenen KC. Posttraumatic stress disorder; combat exposure; and nicotine dependence, alcohol dependence, and major depression in male twins. Comprehensive psychiatry. 2008 May 1; 49(3):297-304.
  605. Phillips K, Gordon AJ, Walley AY. Patients in recovery and opioids. Paper presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 9; Pittsburgh, PA.
  606. Laffaye C, McKellar JD, Ilgen MA, Moos RH. Predictors of 4-year outcome of community residential treatment for patients with substance use disorders. Addiction. 2008 Apr 1; 103(4):671-80.
  607. Burnette ML, Lucas E, Ilgen M, Frayne SM, Mayo J, Weitlauf JC. Prevalence and health correlates of prostitution among patients entering treatment for substance use disorders. Archives of general psychiatry. 2008 Mar 1; 65(3):337-44.
  608. Rosen CS, Kuhn E, Greenbaum MA, Drescher KD. Substance abuse-related mortality among middle-aged male VA psychiatric patients. Psychiatric services (Washington, D.C.). 2008 Mar 1; 59(3):290-6.
  609. Sajatovic M, Coconcea N, Ignacio RV, Blow FC, Hays RW, Cassidy KA, Meyer WJ. Adjunct extended-release valproate semisodium in late life schizophrenia. International journal of geriatric psychiatry. 2008 Feb 1; 23(2):142-7.
  610. Smelson DA, Dixon L, Craig T, Remolina S, Batki SL, Niv N, Owen R. Pharmacological treatment of schizophrenia and co-occurring substance use disorders. CNS Drugs. 2008 Jan 1; 22(11):903-16.
  611. Timko C. Substance use disorders and interpersonal violence. AACN clinical issues. 2008 Jan 1; 12(1):43-54.
  612. Stecker T, Han X, Curran GM, Booth BM. Characteristics of women seeking intensive outpatient substance use treatment in the VA. Journal of women's health. 2007 Dec 1; 16(10):1478-84.
  613. Timko C, DeBenedetti A. A randomized controlled trial of intensive referral to 12-step self-help groups: one-year outcomes. Drug and Alcohol Dependence. 2007 Oct 8; 90(2-3):270-9.
  614. Druss BG, Wang PS, Sampson NA, Olfson M, Pincus HA, Wells KB, Kessler RC. Understanding mental health treatment in persons without mental diagnoses: results from the National Comorbidity Survey Replication. Archives of general psychiatry. 2007 Oct 1; 64(10):1196-203.
  615. Finney JW. Treatment processes and mediators of substance use disorders treatment effects: the benefits of side road excursions. Alcoholism, clinical and experimental research. 2007 Oct 1; 31(10 Suppl):80s-83s.
  616. Gardner TJ, Kosten TR. Human laboratory and neuroimaging studies in substance use disorders: developing new treatment approaches. The American journal of drug and alcohol abuse. 2007 Oct 1; 33(6):765-7.
  617. Gardner TJ, Kosten TR. Pharmacotherapeutic environments for substance use disorders. The American journal of drug and alcohol abuse. 2007 Oct 1; 33(5):627-9.
  618. Gardner TJ, Kosten TR. Therapeutic options and challenges for substances of abuse. Dialogues in Clinical Neuroscience. 2007 Oct 1; 9(4):431-45.
  619. DeMarce JM, Burden JL, Lash SJ, Stephens RS, Grambow SC. Convergent validity of the Timeline Followback for persons with comorbid psychiatric disorders engaged in residential substance use treatment. Addictive Behaviors. 2007 Aug 1; 32(8):1582-92.
  620. Dowdy R, Deal M, Benbow J, Reoux J, Barns R, Bush K, Kivlahan DR. Care management promotes access, engagement and empowerment for difficult to serve veterans with co-occurring psychiatric and substance use disorders. Presented at: VA Transforming Mental Health Care Conference; 2007 Jul 19; Washington, DC.
  621. Massey LS, Walton MA, Murray RM, Barry KL, Chermack ST, Cunningham RM, Booth BM, Blow FC. Predictors of Substance Use Disorders Among Patients Presenting to an Inner-City ER OACH to Prevention. Paper presented at: Research Society on Alcoholism Annual Scientific Meeting; 2007 Jul 12; Chicago, IL.
  622. Hagedorn H, Dieperink E, Dingmann D, Durfee J, Ho SB, Isenhart C, Rettmann N, Willenbring M. The Liver Health Initiative: Promoting Hepatitis Services in Substance Use Disorders Treatment Clinics. Poster session presented at: AcademyHealth Annual Research Meeting; 2007 Jun 4; Orlando, FL.
  623. McGlynn G, Hanks D. CP: VA/HSR&D’s Quality Enhancement Research Initiative Poster. Poster session presented at: AcademyHealth Annual Research Meeting; 2007 Jun 4; Orlando, FL.
  624. Hagedorn H, Dieperink E, Dingmann D, Durfee J, Ho SB, Isenhart C, Rettmann N, Willenbring M. Integrating hepatitis prevention services into a substance use disorder clinic. Journal of substance abuse treatment. 2007 Jun 1; 32(4):391-8.
  625. Moos RH. Theory-based processes that promote the remission of substance use disorders. Clinical Psychology Review. 2007 Jun 1; 27(5):537-51.
  626. Moos RH. Theory-based active ingredients of effective treatments for substance use disorders. Drug and Alcohol Dependence. 2007 May 11; 88(2-3):109-21.
  627. Dookeran NM, Burgess J, Bowman C, Chen Y, Asch S, Gifford A. HIV testing in adults with alcohol and other substance use disorders. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2007 Apr 26; Toronto, Canada.
  628. Ilgen MA, Harris AH, Moos RH, Tiet QQ. Predictors of a suicide attempt one year after entry into substance use disorder treatment. Alcoholism, clinical and experimental research. 2007 Apr 1; 31(4):635-42.
  629. Tiet QQ, Ilgen MA, Byrnes HF, Harris AH, Finney JW. Treatment setting and baseline substance use severity interact to predict patients' outcomes. Addiction. 2007 Mar 1; 102(3):432-40.
  630. Ilgen M, Harris A, Moos R, Tiet Q. Predictors of a suicide attempt one year after entry into substance use disorder treatment. Poster session presented at: VA HSR&D National Meeting; 2007 Feb 22; Arlington, VA.
  631. Schutte K, Ilgen M, Tiet QQ. Patient and program characteristics predicting improved outcomes among individuals with co-occurring psychiatric and substance use disorders. Poster session presented at: VA HSR&D National Meeting; 2007 Feb 21; Arlington, VA.
  632. Tiet QQ, Schutte K. Substance use disorders interact with depressive symptoms to predict depressive outcomes. Poster session presented at: VA HSR&D National Meeting; 2007 Feb 21; Arlington, VA.
  633. Finney J, Wilbourne P, Moos R. Psychosocial treatments for substance use disorders. In: A guide to treatments that work. New York, NY: Oxford University Press; 2007. 179-202 p.
  634. Tracy SW, Trafton JA, Weingardt KR, Aton EG, Humphreys K. How are substance use disorders addressed in VA psychiatric and primary care settings? Results of a national survey. Psychiatric services (Washington, D.C.). 2007 Feb 1; 58(2):266-9.
  635. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Chronic illness with complexities: mental illness and substance use among Veteran clinic users with diabetes. The American journal of drug and alcohol abuse. 2007 Jan 1; 33(6):807-21.
  636. Ilgen MA, Moos RH. Exacerbation of psychiatric symptoms during substance use disorder treatment. Psychiatric services (Washington, D.C.). 2006 Dec 1; 57(12):1758-64.
  637. McGlynn G, Hanks D. CP: VA/HSR&D’s Quality Enhancement Research Initiative Poster. Poster session presented at: Association of Military Surgeons of the United States Annual Meeting; 2006 Nov 8; San Antonio, TX.
  638. Kimerling R, Trafton JA, Nguyen B. Validation of a brief screen for Post-Traumatic Stress Disorder with substance use disorder patients. Addictive Behaviors. 2006 Nov 1; 31(11):2074-9.
  639. Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 2006 Nov 1; 101(11):1546-60.
  640. Kodl M, Fu SS, Joseph AM. Tobacco cessation treatment for alcohol-dependent smokers: when is the best time? Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism. 2006 Oct 1; 29(3):203-7.
  641. Oslin DW, Llorente MD, Malphurs J. Substance use disorders in the elderly. In: Principles and Practice of Geriatric Psychiatry. Philadelphia, PA: Lippincott, Williams, and Wilkins; 2006.
  642. Tiet QQ, Byrnes HF, Barnett P, Finney JW. A practical system for monitoring the outcomes of substance use disorder patients. Journal of substance abuse treatment. 2006 Jun 1; 30(4):337-47.
  643. Timko C, Debenedetti A, Billow R. Intensive referral to 12-Step self-help groups and 6-month substance use disorder outcomes. Addiction. 2006 May 1; 101(5):678-88.
  644. Saxon AJ, Malte CA, Sloan KL, Baer JS, Calsyn DA, Nichol P, Chapko MK, Kivlahan DR. Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment. Medical care. 2006 Apr 1; 44(4):334-42.
  645. Kilbourne AM, Pincus HA, Schutte K, Kirchner JE, Haas GL, Yano EM. Management of mental disorders in VA primary care practices. Administration and policy in mental health. 2006 Mar 1; 33(2):208-14.
  646. McKellar J, Kelly J, Harris A, Moos R. Pretreatment and during treatment risk factors for dropout among patients with substance use disorders. Addictive Behaviors. 2006 Mar 1; 31(3):450-60.
  647. Stein MD, Anderson BJ, Lassor J, Friedmann PD. Receipt of disability payments by substance users: mental and physical health correlates. The American journal on addictions. 2006 Mar 1; 15(2):160-5.
  648. Ilgen MA, Tiet Q, McKellar J, Barnett P, Luna Y, Finney JW. Treatment intensity and symptom severity in patients with substance use disorders. Paper presented at: VA HSR&D National Meeting; 2006 Feb 1; Arlington, VA.
  649. Kilbourne AM, Salloum I, Dausey D, Cornelius JR, Conigliaro J, Xu X, Pincus HA. Quality of care for substance use disorders in patients with serious mental illness. Journal of substance abuse treatment. 2006 Jan 1; 30(1):73-7.
  650. Lebow J, Kelly J, Knobloch-Fedders LM, Moos R. Relationship Factors in Treating Substance Use Disorders. In: Castonguay LG, Beutler LE, editors. Principles of Therapeutic Change That Work. New York, NY: Oxford University Press; 2006. Chapter 15. 293-317 p.
  651. Tiet QQ, Finney JW, Moos RH. Recent sexual abuse, physical abuse, and suicide attempts among male veterans seeking psychiatric treatment. Psychiatric services (Washington, D.C.). 2006 Jan 1; 57(1):107-13.
  652. Frayne SM, Halanych JH, Miller DR, Wang F, Lin H, Pogach L, Sharkansky EJ, Keane TM, Skinner KM, Rosen CS, Berlowitz DR. Disparities in diabetes care: impact of mental illness. Archives of internal medicine. 2005 Dec 12; 165(22):2631-8.
  653. Hagedorn H. The Liver Health Initiative: Integrating Hepatitis Prevention and Referral Services into Substance Use Disorders Treatment. Paper presented at: Agency for Healthcare Research and Quality Translating Research Into Practice and Policy Annual Meeting; 2005 Oct 1; Washington, DC.
  654. Moggi F, Giovanoli A, Sutter M, Humphreys K. Validity and reliability of the German version of the short understanding of substance abuse scale. European Addiction Research. 2005 Oct 1; 11(4):172-9.
  655. Ilgen MA, Tiet Q, Finney JW, Harris AH. Recent suicide attempt and the effectiveness of inpatient and outpatient substance use disorder treatment. Alcoholism, clinical and experimental research. 2005 Sep 1; 29(9):1664-71.
  656. Owen RR, Finney JW, Magruder KM. Report of the HSR&D Field Based Science Advisors for Special Populations: An analysis of VA and non-VA health services research portfolios in mental health, substance use disorders, and posttraumatic stress disorder. Little Rock, AR: Center for Mental Healthcare and Outcomes Research; 2005 Sep 1. Report No.: 1.
  657. Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. Journal of psychiatric practice. 2005 Sep 1; 11(5):315-39.
  658. Bradford DW, Gaynes BN, Kim MM, Kaufman JS, Weinberger M. Can shelter-based interventions improve treatment engagement in homeless individuals with psychiatric and/or substance misuse disorders?: a randomized controlled trial. Medical care. 2005 Aug 1; 43(8):763-8.
  659. Harris KM, Edlund MJ. Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatric services (Washington, D.C.). 2005 Aug 1; 56(8):954-9.
  660. Johnson JE, Finney JW, Moos RH. Predictors of 5-year mortality following inpatient/residential group treatment for substance use disorders. Addictive Behaviors. 2005 Aug 1; 30(7):1300-16.
  661. Hagedorn H, Willenbring ML, Dieperink E, Pexa N, Dingmann D, Durfee J, Ho S. The Liver Health Initiative: Coordinating Hepatitis Prevention and Treatment Referral through a Substance Use Disorders Clinic. Poster session presented at: AcademyHealth Annual Research Meeting; 2005 Jun 1; Boston, MA.
  662. Ilgen M, Tiet Q, Byrnes H, Moos R. Risk of suicide attempt in substance use disorder patients. Paper presented at: Research Society on Alcoholism Annual Scientific Meeting; 2005 Jun 1; Santa Barbara, CA.
  663. Young HE, Rosen CS, Finney JW. A survey of PTSD screening and referral practices in VA addiction treatment programs. Journal of substance abuse treatment. 2005 Jun 1; 28(4):313-9.
  664. Moos RH. Iatrogenic effects of psychosocial interventions for substance use disorders: prevalence, predictors, prevention. Addiction. 2005 May 1; 100(5):595-604.
  665. Kelly JF, Finney JW, Moos R. Substance use disorder patients who are mandated to treatment: characteristics, treatment process, and 1- and 5-year outcomes. Journal of substance abuse treatment. 2005 Apr 1; 28(3):213-23.
  666. Moggi F, Giovanoli A, Moos R. Swiss and United States treatment programs for substance use disorders: Program characteristics, psychiatric comorbidity, and one-year outcomes. Paper presented at: European Psychiatric Association Annual Congress; 2005 Apr 1; Munich, Germany.
  667. Wagner TH, Chen S. An economic evaluation of inpatient residential treatment programs in the Department of Veterans Affairs. Medical care research and review : MCRR. 2005 Apr 1; 62(2):187-204.
  668. DeMarce J, Stephens R, Lash S, Grambow SC. Comorbid Psychiatric Disorders with Substance Use Disorders: Does Comorbidity Moderate Rates of Aftercare Attendance and Substance Use Outcomes? Paper presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2004 Nov 1; New Orleans, LA.
  669. Moos R. How Can Treatment and Clients Inform and Influence Research on Substance Use Disorders. Paper presented at: Choice, Behavioural Economics, and Addiction Annual Conference; 2004 Nov 1; Brisbane, Australia.
  670. Ilgen M, Tiet Q, Moos R. Response to inpatient substance use treatment in suicidal and non-suicidal patients. Paper presented at: American Psychological Association Annual Convention; 2004 Jul 2; Honolulu, HI.
  671. Black DW, Carney CP, Forman-Hoffman VL, Letuchy E, Peloso P, Woolson RF, Doebbeling BN. Depression in veterans of the first Gulf War and comparable military controls. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 2004 Apr 1; 16(2):53-61.
  672. Ilgen M, Tiet Q. Treatment setting and suicidality in patients with substance use disorders. Paper presented at: VA HSR&D National Meeting; 2004 Mar 1; Washington, DC.
  673. Tracy S, Trafton J, Humphreys K. VA psychiatry programs underestimate the prevalence of patients' substance use disorders and rarely provide specialized substance use disorder treatment. Veterans Affairs Central Office; 2004 Jan 1.
  674. Bonner L, Chaney E, Felker B, Simon B. Multi-Disciplinary Development of a Collaborative Care Process. Paper presented at: VA QUERI National Meeting; 2003 Dec 10; Washington, DC.
  675. Curran GM, Kirchner JE, Allee E, Booth BM. Datapoints: detection of substance use disorders in veterans affairs primary care clinics. Psychiatric services (Washington, D.C.). 2003 Oct 1; 54(10):1326.
  676. Humphreys K. Substance use disorders and juvenile justice. Paper presented at: American Academy of Child and Adolescent Psychiatry Annual Meeting; 2003 Oct 1; San Francisco, CA.
  677. Kelly J, Humphreys K. Self-help for substance use disorders: Evidence of effectiveness and strategies to maximize benefits. Paper presented at: Treatment of Addictive Disorders Annual Conference; 2003 Sep 1; Biloxi, MI.
  678. Osher FC, Goldberg RW, McNary SW, Swartz MS, Essock SM, Butterfield MI, Rosenberg SD. Substance abuse and the transmission of hepatitis C among persons with severe mental illness. Psychiatric services (Washington, D.C.). 2003 Jun 1; 54(6):842-7.
  679. Rosenberg SD, Swanson JW, Wolford GL, Osher FC, Swartz MS, Essock SM, Butterfield MI, Marsh BJ. The five-site health and risk study of blood-borne infections among persons with severe mental illness. Psychiatric services (Washington, D.C.). 2003 Jun 1; 54(6):827-35.
  680. Curran GM, Sullivan G, Williams K, Han X, Collins K, Keys J, Kotrla KJ. Emergency department use of persons with comorbid psychiatric and substance abuse disorders. Annals of Emergency Medicine. 2003 May 1; 41(5):659-67.
  681. Kelly JF, McKellar JD, Moos R. Major depression in patients with substance use disorders: relationship to 12-Step self-help involvement and substance use outcomes. Addiction. 2003 Apr 1; 98(4):499-508.
  682. Brennan PL, Nichol AC, Moos RH. Older and younger patients with substance use disorders: outpatient mental health service use and functioning over a 12-month interval. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2003 Mar 1; 17(1):42-8.
  683. Ritsher JB, McKellar JD, Finney JW, Otilingam PG, Moos RH. Psychiatric comorbidity, continuing care and mutual help as predictors of five-year remission from substance use disorders. Journal of Studies On Alcohol. 2002 Nov 1; 63(6):709-15.
  684. Rosen CS, Ouimette PC, Sheikh JI, Gregg JA, Moos RH. Physical and sexual abuse history and addiction treatment outcomes. Journal of Studies On Alcohol. 2002 Nov 1; 63(6):683-7.
  685. Brennan PL, Nichols KA, Moos RH. Long-term use of VA mental health services by older patients with substance use disorders. Psychiatric services (Washington, D.C.). 2002 Jul 1; 53(7):836-41.
  686. Davis TM, Carpenter KM, Malte CA, Carney M, Chambers S, Saxon AJ. Women in addictions treatment: comparing VA and community samples. Journal of substance abuse treatment. 2002 Jul 1; 23(1):41-8.
  687. Curran GM, Kirchner JE, Booth BM. Detection of substance use disorders in VA primary care clinics. Paper presented at: Research Society on Alcoholism Annual Scientific Meeting; 2002 Jun 5; San Francisco, CA.
  688. Moos RH, Nichol AC, Moos BS. Global Assessment of Functioning ratings and the allocation and outcomes of mental health services. Psychiatric services (Washington, D.C.). 2002 Jun 1; 53(6):730-7.
  689. Otilingam PG, Ritsher JB, Finney JW, Moos RH, Suchinsky RT. Outcomes Monitoring for Patients with Substance Use Disorders: V. Cohort 3 Patients' Treatment and Treatment Outcomes. Department of Veterans Affairs; 2002 Apr 1.
  690. Whitney S, Kelly J, Myers M, Brown S. Parental substance use, family support and outcome following treatment for adolescent psychoactive substance use disorders. Journal of Child & Adolescent Substance Abuse. 2002 Apr 1; 11(4):67-81.
  691. Moos RH, Nichol AC, Moos BS. Risk factors for symptom exacerbation among treated patients with substance use disorders. Addiction. 2002 Jan 1; 97(1):75-85.
  692. Willenbring M, Kivlahan D, Grillo M. Evidence-based clinical practice guidelines in substance use disorders: a survey of VA substance abuse program leaders. Palo Alto, CA: QUERI Substance Abuse Module; 2001 Sep 15.
  693. Kivlahan D, Miller S, Willenbring M, McNicholas L. VHA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders in the Primary Care setting. Washington, DC: Office of Performance and Quality, VHA and Quality Management Directorate, United States Army MEDCOM; 2001 Apr 1. Report No.: Draft Version 1.0.
  694. Moos R, Schaefer J, Andrassy J, Moos B. Outpatient mental health care, self-help groups, and patients' one-year treatment outcomes. Journal of Clinical Psychology. 2001 Mar 1; 57(3):273-87.
  695. Olfson M, Zarin DA, Mittman BS, McIntyre JS. Is gender a factor in psychiatrists' evaluation and treatment of patients with major depression? Journal of affective disorders. 2001 Mar 1; 63(1-3):149-57.
  696. Booth BM, Blow FC, Loveland Cook CA. Persistence of impaired functioning and psychological distress after medical hospitalization for men with co-occurring psychiatric and substance use disorders. Journal of general internal medicine. 2001 Jan 1; 16(1):57-65.
  697. Brennan PL, Kagay CR, Geppert JJ, Moos RH. Predictors and outcomes of outpatient mental health care: a 4-year prospective study of elderly Medicare patients with substance use disorders. Medical care. 2001 Jan 1; 39(1):39-49.
  698. Brennan PL, Kagay CR, Geppert JJ, Moos RH. Elderly Medicare inpatients with substance use disorders: characteristics and predictors of hospital readmissions over a four-year interval. Journal of Studies On Alcohol. 2000 Nov 1; 61(6):891-5.
  699. Gold PB, Meisler N, DuRoss D, Santos AB. Assertive community treatment for indigent persons with severe substance use disorders. Paper presented at: American Public Health Association Annual Meeting and Exposition; 2000 Nov 1; Boston, MA.
  700. Moos RH, Finney JW, Federman EB, Suchinsky R. Specialty mental health care improves patients' outcomes: findings from a nationwide program to monitor the quality of care for patients with substance use disorders. Journal of Studies On Alcohol. 2000 Sep 1; 61(5):704-13.
  701. Kales HC, Blow FC, Bingham CR, Copeland LA, Mellow AM. Race and inpatient psychiatric diagnoses among elderly veterans. Psychiatric services (Washington, D.C.). 2000 Jun 1; 51(6):795-800.
  702. Moos RH, Finney JW, Moos BS. Inpatient substance abuse care and the outcome of subsequent community residential and outpatient care. Addiction. 2000 Jun 1; 95(6):833-46.
  703. Moos RH, Finney JW, Suchinsky RT. Outcomes monitoring for patients with substance use disorders: IV. Cohort 2 patients' 6-12 month treatment outcomes. 2000 Apr 1. 1-48 p.
  704. Moos RH, McCoy L, Moos BS. Global assessment of functioning (GAF) ratings: determinants and role as predictors of one-year treatment outcomes. Journal of Clinical Psychology. 2000 Apr 1; 56(4):449-61.
  705. Timko C, Lesar M, Engelbrekt M, Moos RH. Changes in services and structure in community residential treatment facilities for substance abuse patients. Psychiatric services (Washington, D.C.). 2000 Apr 1; 51(4):494-8.
  706. Sloan KL, Kivlahan D, Saxon AJ. Detecting bipolar disorder among treatment-seeking substance abusers. The American journal of drug and alcohol abuse. 2000 Feb 1; 26(1):13-23.
  707. Finney JW, Moos RH, Timko C. The course of treated and untreated substance use disorders: Remission and resolution, relapse and mortality. In: McCrady BS, Epstein EE, editors. Addictions: A comprehensive guidebook. New York, NY: Oxford University Press; 1999.
  708. Moos RH, Moos BS, Andrassy JM. Outcomes of four treatment approaches in community residential programs for patients with substance use disorders. Psychiatric services (Washington, D.C.). 1999 Dec 1; 50(12):1577-83.
  709. Moggi F, Ouimette PC, Finney JW, Moos RH. Effectiveness of treatment for substance abuse and dependence for dual diagnosis patients: a model of treatment factors associated with one-year outcomes. Journal of Studies On Alcohol. 1999 Nov 1; 60(6):856-66.
  710. Moos RH, Federman B, Finney J, Suchinsky R. Outcomes monitoring for patients with substance use disorders: II. Cohort 1 patients' 6-12 month treatment outcomes. PERC, HSR&D Center for Health Care Evaluation, MHSHG; 1999 Sep 1. Report No.: 2.
  711. Moos RH, Federman B, Finney J, Suchinsky R. Outcomes monitoring for patients with substance use disorders: III. Cohort 2 patients' characteristics and treatment at baseline. Palo Alto, CA: PERC, HSR&D Center for Health Care Evaluation, MHSHG; 1999 Sep 1. Report No.: 3.
  712. Moos RH, Finney JW, Ouimette PC, Suchinsky RT. A comparative evaluation of substance abuse treatment: I. Treatment orientation, amount of care, and 1-year outcomes. Alcoholism, clinical and experimental research. 1999 Mar 1; 23(3):529-36.
  713. Ouimette PC, Gima K, Moos RH, Finney JW. A comparative evaluation of substance abuse treatment IV. The effect of comorbid psychiatric diagnoses on amount of treatment, continuing care, and 1-year outcomes. Alcoholism, clinical and experimental research. 1999 Mar 1; 23(3):552-7.
  714. Chun C, Ouimette PC, Kimerling R, Moos R. Gender differences in addiction severity, health status, and psychosocial functioning in veterans with substance use disorders. Paper presented at: VA HSR&D National Meeting; 1999 Feb 1; Washington, DC.
  715. Maynard C, Cox GB. Psychiatric hospitalization of persons with dual diagnoses: estimates from two national surveys. Psychiatric services (Washington, D.C.). 1998 Dec 1; 49(12):1615-7.
  716. Ouimette PC, Ahrens C, Moos RH, Finney JW. During treatment changes in substance abuse patients with posttraumatic stress disorder. The influence of specific interventions and program environments. Journal of substance abuse treatment. 1998 Nov 1; 15(6):555-64.
  717. Blow FC, Barry KL, BootsMiller BJ, Copeland LA, McCormick R, Visnic S. Longitudinal assessment of inpatient use and functioning of seriously mentally ill veterans with and without co-occurring substance use disorders. Journal of psychiatric research. 1998 Sep 1; 32(5):311-9.
  718. Friedmann PD, Saitz R, Samet JH. Management of adults recovering from alcohol or other drug problems: relapse prevention in primary care. JAMA : the journal of the American Medical Association. 1998 Apr 15; 279(15):1227-31.
  719. Williams W, Weiss TW, Edens A, Johnson M, Thornby JI. Hospital utilization and personality characteristics of veterans with psychiatric problems. Psychiatric services (Washington, D.C.). 1998 Mar 1; 49(3):370-5.
  720. Kirchner JE, Owen RR, Nordquist C, Fischer EP. Diagnosis and management of substance use disorders among inpatients with schizophrenia. Psychiatric services (Washington, D.C.). 1998 Jan 1; 49(1):82-5.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.
<--- --->